合成路线1
该中间体在本合成路线中的序号:
(VIII) The cyclization of 4-benzoyloxycyclohexanone (I) with ethyl 2-bromomethylacrylate (II) and propylamine (III) in refluxing toluene gives ethyl 1-propyl-6-benzoyloxy-1,2,3,4,5,6,7,8-octahydroquinoline-3-carboxylate (IV), which is reduced with sodium cyanoborohydride in methanol yielding the corresponding decahydro derivative (V). Debenzoylation of (V) with NaOH in methanol affords the hydroxyquinoline (VI), which is oxidized with CrO3-pyr giving ethyl 1-propyl-6-oxodecahydroquinoline-3-carboxylate (VII). The reaction of (VII) with dimethylformamide dimethylacetal (VIII) in refluxing toluene yields ethyl 1-propyl-6-oxo-7-(dimethylaminomethylene)decahydroquinoline-3-carboxylate (IX), which is cyclized with hydrazine in ethanol affording ethyl 5-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline-7-carboxylic acid (X). The reduction of (X) with LiAlH4 in THF gives the corresponding hydroxymethyl derivative (XI), which is esterified with methanesulfonyl chloride to the mesyl ester (XII). Finally, this compound is treated with methyl mercaptane and NaH in DMF.
【1】
Bach, N.; Kornfeld, E.C. (Eli Lilly and Company); Prolactin inhibiting octahydropyrazolo[3,4-g]quinolines. DD 148517; EP 0013787; ES 482087; FR 2446820; FR 2446821; FR 2446822; GB 2040915; GB 2092579; US 4198415 .
|
【2】
Nohria, Y.; Castaner, J.; Serradell, M.N.; Blancafort, P.; LY-141,865. Drugs Fut 1983, 8, 10, 858.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16767 |
4-oxocyclohexyl benzoate
|
|
C13H14O3 |
详情 |
详情
|
(II) |
11328 |
ethyl 2-(bromomethyl)acrylate
|
17435-72-2 |
C6H9BrO2 |
详情 | 详情
|
(III) |
23923 |
1-propanamine
|
107-10-8 |
C3H9N |
详情 | 详情
|
(IV) |
36234 |
ethyl 6-(benzoyloxy)-1-propyl-1,2,3,4,5,6,7,8-octahydro-3-quinolinecarboxylate
|
|
C22H29NO4 |
详情 |
详情
|
(V) |
36235 |
ethyl (4aR,8aR)-6-(benzoyloxy)-1-propyldecahydro-3-quinolinecarboxylate
|
|
C22H31NO4 |
详情 |
详情
|
(VI) |
36236 |
ethyl (4aR,8aR)-6-hydroxy-1-propyldecahydro-3-quinolinecarboxylate
|
|
C15H27NO3 |
详情 |
详情
|
(VII) |
36237 |
ethyl (4aR,8aR)-6-oxo-1-propyldecahydro-3-quinolinecarboxylate
|
|
C15H25NO3 |
详情 |
详情
|
(VIII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(IX) |
36238 |
ethyl (4aR,8aR)-7-[(Z)-(dimethylamino)methylidene]-6-oxo-1-propyloctahydro-3(1H)-quinolinecarboxylate
|
|
C18H30N2O3 |
详情 |
详情
|
(X) |
36239 |
ethyl (4aR,8aR)-5-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline-7-carboxylate
|
|
C16H25N3O2 |
详情 |
详情
|
(XI) |
36240 |
[(4aR,8aR)-5-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinolin-7-yl]methanol
|
|
C14H23N3O |
详情 |
详情
|
(XII) |
36241 |
[(4aR,8aR)-5-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinolin-7-yl]methyl methyl sulfone; (4aR,8aR)-7-[(methylsulfonyl)methyl]-5-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline
|
|
C15H25N3O2S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) The protection of (XI) with dihydropyran as usual affords the bistetrahydropyranylether (XII), which is deacetylated with K2CO3 in methanol to the 5-hydroxyester (XIII). Total hydrolysis of (XIII) with aqueous KOH gives the diacid (XIV), which is submitted to a dehydrative decarboxylation with N,N-dimethylformamide dimethyl acetal (A) in CHCl3 yielding the protected carbacyclin (XV). Finally, this compound is deprotected with aqueous acetic acid and hydrolyzed with KOH.
【1】
Sakai, K.; Amemiya, S.; Kojima, K.; A novel synthesis (±)-carbacyclin. Chem Pharm Bull 1984, 32, 4, 1349-54. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XI) |
34345 |
ethyl (3aS,4S,5R,6aR)-2-[1-(acetoxy)-5-methoxy-5-oxopentyl]-4-[(E,3S)-3-hydroxy-1-octenyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]octahydro-2-pentalenecarboxylate
|
|
C33H54O9 |
详情 |
详情
|
(XII) |
34346 |
ethyl (3aS,4S,5R,6aR)-2-[1-(acetoxy)-5-methoxy-5-oxopentyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-4-[(E,3S)-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-octenyl]octahydro-2-pentalenecarboxylate
|
|
C39H64O10 |
详情 |
详情
|
(XIII) |
34347 |
ethyl (3aS,4S,5R,6aR)-2-(1-hydroxy-5-methoxy-5-oxopentyl)-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-4-[(E,3S)-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-octenyl]octahydro-2-pentalenecarboxylate
|
|
C37H62O9 |
详情 |
详情
|
(XIV) |
34348 |
(3aS,4S,5R,6aR)-2-(4-carboxy-1-hydroxybutyl)-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-4-[(E,3S)-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-octenyl]octahydro-2-pentalenecarboxylic acid
|
|
C34H56O9 |
详情 |
详情
|
(XV) |
34349 |
methyl 5-[(3aS,4S,5R,6aR)-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-4-[(E,3S)-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1-octenyl]hexahydro-2(1H)-pentalenylidene]pentanoate
|
|
C34H56O6 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(IV) The condensation of ethyl acetate (I) with 4-picoline (II) by means of n-butyllithium in THF gives 1-(4-pyridyl)propanone (III), which by reaction with the dimethylacetal of dimethylformamide (IV) in refluxing HMPT is converted into 4-dimethylamino-3-(4-pyridyl)-3-buten-2-one (V). Finally, this compound is cyclized with cyanacetamide (VI) by means of sodium methoxide in refluxing DMF.
【1】
Lehser, G.Y.; Philion, R.E.; Page, D.F.; Opalka, C.J. (Sterling Winthrop Inc.); 5-(pyridinyl)-2(1H)-pyridinones, useful as cardiotonic agents and their preparation. DE 3044568; FR 2470124; GB 2065642; NL 8006399 .
|
【2】
Serradell, M.N.; Castaner, J.; Blancafort, P.; WIN-47,203. Drugs Fut 1982, 7, 10, 757.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17491 |
ethyl acetate
|
141-78-6 |
C4H8O2 |
详情 | 详情
|
(II) |
31150 |
4-methylpyridine
|
108-89-4 |
C6H7N |
详情 | 详情
|
(III) |
32092 |
1-(4-pyridinyl)acetone
|
|
C8H9NO |
详情 |
详情
|
(IV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(V) |
32093 |
(E)-4-(dimethylamino)-3-(4-pyridinyl)-3-buten-2-one
|
|
C11H14N2O |
详情 |
详情
|
(VI) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
1) The condensation of N,N'-di(benzyloxycarbonyl)actinamine (I) with the L-glucose nitrosodimer (II) in DMF gives the oxime adduct (III), which is cyclized by means of aqueous HCl yielding the hemiketal triacetate (IV). The treatment of (IV) with anhydrous KHCO3 in acetonitrile affords the enone acetate (V), which is deacetylated with K2HPO4 in methanol to give N,N'-di(benzyloxycarbonyl)dehydrospectinomycin (VI). The hydrogenation of (VI) with H2 over Pd/BaSO4 in pyridine - isopropanol yields free spectinomycin (VII), which is protected again with benzyloxycarbonyl chloride as usual to give N,N'-di(benzyloxycarbonyl)spectinomycin (VIII). The formylation of (VIII) with formic acid - acetic anhydride gives the 2,6-di-O-formyl derivative (IX), which by treatment with acetic anhydride and dimethylaminopyridine (DMAP) is converted into the enol acetate (X).
The reaction of (X) with dibromodimethylhydantoin (DBMH) in refluxing CCl4 under visible light illumination affords the unsaturated ketone (XI), which is treated with dimethylformamide dimethyl acetal in hot DMF, yielding the dimethylaminovinylene compound (XII).
【1】
White, D.R.; Mizsak, S.A.; Birkenmeyer, R.D.; Thomas, R.C.; Wiley, V.H.; The stereospecific synthesis of spectinomycin. Tetrahedron Lett 1979, 30, 2737-40.
|
【2】
White, D.R. (Pharmacia Corp.); 6'-Alkylspectinomycins. DE 3308196; US 4532336 .
|
【3】
Cain, G.A.; White, D.R.; The synthesis of trospectomycin (6'-n-propylspectinomycin, U-63,366F). Tetrahedron Lett 1989, 30, 12, 1469-72.
|
【4】
White, D.R.; Maring, C.J.; Cain, G.A.; Synthesis and in vitro antibacterial properties of alkylspectinomycin analogs. J Antibiot 1983, 36, 3, 339-42.
|
【5】
Castaner, J.; Patoia, L.; Trospectomycin Sulfate. Drugs Fut 1991, 16, 4, 323.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(I) |
10759 |
(1R,3S,4R,6S)-3-[Carboxy(methyl)amino]-2,4,5,6-tetrahydroxycyclohexyl(methyl)carbamic acid
|
|
C10H18N2O8 |
详情 |
详情
|
(II) |
10760 |
(2S,3R,4S,5S,6S)-3-(acetoxy)-2-[(acetoxy)methyl]-5-[[[[(2S,3S,4S,5R,6S)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-2-chlorotetrahydro-2H-pyran-3-yl](oxo)-lambda(5)-azanylidene]methylene](oxo)-lambda(5)-azanyl]-6-chlorotetrahydro-2H-pyran-4-yl acetate
|
|
C25H32Cl2N2O16 |
详情 |
详情
|
(III) |
10761 |
(2S,3S,4S,6R)-3-(acetoxy)-2-[(acetoxy)methyl]-6-([(2R,3S,5R,6S)-3,5-bis[[(benzyloxy)carbonyl](methyl)amino]-2,4,6-trihydroxycyclohexyl]oxy)-5-(hydroxyimino)tetrahydro-2H-pyran-4-yl acetate
|
|
C36H45N3O16 |
详情 |
详情
|
(IV) |
10762 |
(2S,3S,4R,4aS,5aS,6R,7R,8S,9R,9aS,10aR)-3-(acetoxy)-2-[(acetoxy)methyl]-6,8-bis[[(benzyloxy)carbonyl](methyl)amino]-4a,7,9-trihydroxydecahydro-2H-pyrano[2,3-b][1,4]benzodioxin-4-yl acetate
|
|
C36H44N2O16 |
详情 |
详情
|
(V) |
10763 |
(5aR,6S,7S,8R,9S,9aR,10aR)-6,8-bis[[(benzyloxy)carbonyl](methyl)amino]-7,9-dihydroxy-2-methyl-4-oxo-5a,6,7,8,9,9a-hexahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4(10aH)-yl acetate
|
|
C32H36N2O12 |
详情 |
详情
|
(VI) |
10764 |
benzyl (4aR,5aR,6S,7S,8R,9S,9aR,10aR)-6-[[(benzyloxy)carbonyl](methyl)amino]-4a,7,9-trihydroxy-2-methyl-4-oxo-4a,5a,6,7,8,9,9a,10a-octahydro-4H-pyrano[2,3-b][1,4]benzodioxin-8-yl(methyl)carbamate
|
|
C30H34N2O11 |
详情 |
详情
|
(VII) |
10765 |
(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-4a,7,9-Trihydroxy-2-methyl-6,8-bis(methylamino)decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one
|
|
C14H24N2O7 |
详情 |
详情
|
(VIII) |
10766 |
benzyl (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-6-[[(benzyloxy)carbonyl](methyl)amino]-4a,7,9-trihydroxy-2-methyl-4-oxodecahydro-2H-pyrano[2,3-b][1,4]benzodioxin-8-yl(methyl)carbamate
|
|
C30H36N2O11 |
详情 |
详情
|
(IX) |
10767 |
benzyl (2R,4aR,5aR,6R,7R,8R,9S,9aS,10aS)-6-[[(benzyloxy)carbonyl](methyl)amino]-7,9-bis(formyloxy)-4a-hydroxy-2-methyl-4-oxodecahydro-2H-pyrano[2,3-b][1,4]benzodioxin-8-yl(methyl)carbamate
|
|
C32H36N2O13 |
详情 |
详情
|
(X) |
10768 |
(2R,4aS,5aR,6R,7R,8R,9S,9aS,10aS)-6,8-bis[[(benzyloxy)carbonyl](methyl)amino]-7,9-bis(formyloxy)-4a-hydroxy-2-methyl-4a,5a,6,7,8,9,9a,10a-octahydro-2H-pyrano[2,3-b][1,4]benzodioxin-4-yl acetate
|
|
C34H38N2O14 |
详情 |
详情
|
(XI) |
10769 |
(5aR,6R,7R,8R,9S,9aS,10aR)-6,8-bis[[(benzyloxy)carbonyl](methyl)amino]-7,9-bis(formyloxy)-2-methyl-4-oxo-5a,6,7,8,9,9a-hexahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4(10aH)-yl acetate
|
|
C34H36N2O14 |
详情 |
详情
|
(XII) |
10770 |
(5aR,6S,7S,8R,9S,9aR,10aR)-6,8-bis[[(benzyloxy)carbonyl](methyl)amino]-2-[(E)-2-(dimethylamino)ethenyl]-7,9-dihydroxy-4-oxo-5a,6,7,8,9,9a-hexahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4(10aH)-yl acetate
|
|
C35H41N3O12 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(XIV) The reaction of 4-benzoyloxycyclohexanone (I) with pyrrolidine (II) by means of p-toluenesulfonic acid in refluxing benzene gives the corresponding enamine (III), which is cyclized with acrylamide (IV) in refluxing dioxane yielding the mixture of hexahydroquinolones (V) and (VI). Benzylation of this mixture with benzylbromide (A) and NaH in THF affords the mixture of N-benzylquinolones (VII) and (VIII), which is reduced with LiAlH4 to the mixture of N-benzylhexahydroquinolines (IX) and (X). The reduction of this mixture with sodium cyanoborohydride in THF affords trans-1-benzyl-6-hydroxydecahydro quinoline (XI), which by reaction with BN in CH2Cl2 is converted to trans-1-cyano-6-hydroxydecahydro quinoline (XII). Oxidation of (XII) with CrO3/pyridine in CH2Cl2 gives the corresponding quinolone (XIII), which by reaction with dimethylformamide dimethyl acetal (XIV) in refluxing benzene is converted to 1-cyano-6-oxo-7-(dimethylaminomethylene)decahydroquinoline (XV). The cyclization of (XV) with hydrazine in refluxing methanol affords 5-cyano-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline (XVI), which by a reductive cleavage with Zn and acetic acid gives 4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline (XVII). Finally, this compound is alkylated with propionaldehyde (B) and sodium cyanoborohydride in methanol.
【1】
Bach, N.; Kornfeld, E.C. (Eli Lilly and Company); Prolactin inhibiting octahydropyrazolo[3,4-g]quinolines. DD 148517; EP 0013787; ES 482087; FR 2446820; FR 2446821; FR 2446822; GB 2040915; GB 2092579; US 4198415 .
|
【2】
Serradell, M.N.; Castaner, J.; Castaner, R.M.; Mannhold, R.; Quinpirole Hydrochloride. Drugs Fut 1987, 12, 6, 558.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(B) |
15966 |
propionaldehyde
|
123-38-6 |
C3H6O |
详情 | 详情
|
(I) |
16967 |
N-(tert-butyl)-5-propyl-2-thiophenecarboxamide
|
|
C12H19NOS |
详情 |
详情
|
(II) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(III) |
28829 |
4-(1-pyrrolidinyl)-3-cyclohexen-1-yl benzoate
|
|
C17H21NO2 |
详情 |
详情
|
(IV) |
10851 |
Acrylamide
|
79-06-1 |
C3H5NO |
详情 | 详情
|
(V) |
28830 |
2-oxo-1,2,3,4,5,6,7,8-octahydro-6-quinolinyl benzoate
|
|
C16H17NO3 |
详情 |
详情
|
(VI) |
28831 |
2-oxo-1,2,3,4,4a,5,6,7-octahydro-6-quinolinyl benzoate
|
|
C16H17NO3 |
详情 |
详情
|
(VII) |
28832 |
1-benzyl-2-oxo-1,2,3,4,5,6,7,8-octahydro-6-quinolinyl benzoate
|
|
C23H23NO3 |
详情 |
详情
|
(VIII) |
28833 |
1-benzyl-2-oxo-1,2,3,4,4a,5,6,7-octahydro-6-quinolinyl benzoate
|
|
C23H23NO3 |
详情 |
详情
|
(IX) |
28834 |
1-benzyl-6-hydroxy-3,4,5,6,7,8-hexahydro-2(1H)-quinolinone
|
|
C16H19NO2 |
详情 |
详情
|
(X) |
28835 |
1-benzyl-6-hydroxy-3,4,4a,5,6,7-hexahydro-2(1H)-quinolinone
|
|
C16H19NO2 |
详情 |
详情
|
(XI) |
28836 |
(4aR,8aR)-1-benzyldecahydro-6-quinolinol
|
|
C16H23NO |
详情 |
详情
|
(XII) |
28837 |
(4aR,8aR)-1-cyanodecahydro-6-quinolinol
|
|
C10H16N2O |
详情 |
详情
|
(XIII) |
28838 |
(4aR,8aR)-1-cyanooctahydro-6(2H)-quinolinone
|
|
C10H14N2O |
详情 |
详情
|
(XIV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XV) |
28839 |
(4aR,8aR)-1-cyano-7-[(Z)-(dimethylamino)methylidene]octahydro-6-quinolinone
|
|
C13H19N3O |
详情 |
详情
|
(XVI) |
28840 |
(4aR,8aR)-5-cyano-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline
|
|
C11H14N4 |
详情 |
详情
|
(XVII) |
28841 |
(4aR,8aR)-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline
|
|
C10H15N3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(VII) The demethylation of 1-(4-methoxyphenyl)acetone (I) by means of AlCl3 gives the corresponding 4-hydroxy compound (III), which is condensed with epichlorohydrin (III), yielding the expected oxiranylmethyl ether (IV). The addition of 1-(2-methoxyphenyl)piperazine (V) to the epoxide ring of (IV) affords the isopropyl alcohol derivative (VI), which is condensed with dimethylformamide dimethylacetal (VII) to afford the dimethylaminobutenone (VIII). Finally, this compound is cyclized with 2-cyanoacetamide (IX) by means of sodium ethoxide, providing the target pyridone.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10038 |
4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone
|
122-84-9 |
C10H12O2 |
详情 | 详情
|
(II) |
43654 |
1-(4-hydroxyphenyl)acetone
|
|
C9H10O2 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
43655 |
1-[4-(2-oxiranylmethoxy)phenyl]acetone
|
|
C12H14O3 |
详情 |
详情
|
(V) |
11882 |
1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine
|
35386-24-4 |
C11H16N2O |
详情 | 详情
|
(VI) |
43656 |
1-(4-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl)acetone
|
|
C23H30N2O4 |
详情 |
详情
|
(VII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VIII) |
43657 |
(Z)-4-(dimethylamino)-3-(4-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl)-3-buten-2-one
|
|
C26H35N3O4 |
详情 |
详情
|
(IX) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The condensation of N-(3-acetylphenyl)acetamide (I) with dimethylformamide dimethylacetal (II) at reflux temperature gives N-[3-[3-(dimethylamino)-2-propenoyl]phenyl]acetamide (III), which is alkylated with NaH and ethyl iodide to the corresponding N-ethyl derivative (IV). Finally, this compound is cyclized with 3-aminopyrazole-4-carbonitrile (V) in refluxing acetic acid.
【1】
Mealy, N.; Castaner, J.; Zaleplon. Drugs Fut 1996, 21, 1, 37.
|
【2】
Dusza, J.P.; Tomcufcik, A.S.; Albright, J.D. (American Cyanamid Co.); [7-(3-Disubstd. amino)phenyl]pyrazolo[1,5-a]pyrimidines. EP 0208846; JP 1986260083; JP 1995084468; US 4626538 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11983 |
3'-Acetamidoacetophane; m-Acetamidoacetophenone; N-(3-Acetylphenyl)acetamide
|
7463-31-2 |
C10H11NO2 |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
11985 |
N-[3-[(E)-3-(Dimethylamino)-2-propenoyl]phenyl]acetamide
|
|
C13H16N2O2 |
详情 |
详情
|
(IV) |
11986 |
N-[3-[(E)-3-(Dimethylamino)-2-propenoyl]phenyl]-N-ethylacetamide
|
|
C15H20N2O2 |
详情 |
详情
|
(V) |
11987 |
3-Amino-4-pyrazolecarbonitrile; 3-Amino-1H-pyrazole-4-carbonitrile; 3-Amino-4-cyanopyrazole
|
16617-46-2 |
C4H4N4 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(VIII) Three related new synthetic routes for E-1020 have been reported:
1) The cyclization of 2-bromoacetaldehyde diethylacetal (I) with 2-aminopyridine-5-carboxylic acid methyl ester (II) by means of HCl in hot water gives imidazo[1,2-a]pyridine-6-carboxylic acid methyl ester (III), which is reduced with dibutylaluminum hydride in dichloromethane to the corresponding aldehyde (IV). The condensation of (IV) with nitroethane (V) by means of butylamine in refluxing ethanol affords 6-(2-nitro-1-propenyl)imidazo[1,2-a]pyridine (VI), which is treated with Fe-FeCl2-HCl in hot ethanol-water to give 1-(imidazo[1,2-a]pyridyl-6-yl)-2-propanone (VII). The condensation of (VII) with dimethylformamide dimethylacetal (VIII) in hot DMF yields 4-(dimethylamino)-3-(imidazo[1,2-a]pyridin-6-yl)-3-buten-2-one (IX), which is finally cyclized with cyanacetamide (X) by means of sodium methoxide in hot DMF.
2) The cyclization of acetal (I) with 2-amino-5-bromopyridine (XI) as before gives 6-bromoimidazo[1,2-a]pyridine (XII), which is condensed with potassium acetylacetonate (XIII) by means of KI and Cu2I2 in hot DMF yielding the adduct (XIV). The cleavage of (XIV) with NaOH and then with HCl gives the propanone (VII), already obtained.
3) The condensation of the bromo derivative (XII) with 3-chloro-2-methylpropene (XV) by means of ethylmagnesium bromide in hot THF gives 6-isobutenylimidazo[1,2-a]pyridine (XVI), which is ozonolyzed with O3 in methanol-water-HCl to yield the propanone (VII), already obtained.
【1】
Yamanaka, M.; Miyake, K.; Suda, S.; Ohhara, H.; Ogawa, T.; Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives. Chem Pharm Bull 1991, 39, 6, 1556-67.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12113 |
2-Bromo-1-ethoxyethyl ethyl ether; 2-Bromo-1,1-diethoxyethane; Bromoacetaldehyde diethylacetal
|
2032-35-1 |
C6H13BrO2 |
详情 | 详情
|
(II) |
12114 |
methyl 6-aminonicotinate
|
|
C7H8N2O2 |
详情 |
详情
|
(III) |
12115 |
methyl imidazo[1,2-a]pyridine-6-carboxylate
|
|
C9H8N2O2 |
详情 |
详情
|
(IV) |
12116 |
Imidazo[1,2-a]pyridine-6-carbaldehyde
|
|
C8H6N2O |
详情 |
详情
|
(V) |
12117 |
Nitroethane; 1-Nitroethane
|
79-24-3 |
C2H5NO2 |
详情 | 详情
|
(VI) |
12118 |
6-[(E)-2-Nitro-1-propenyl]imidazo[1,2-a]pyridine
|
|
C10H9N3O2 |
详情 |
详情
|
(VII) |
12119 |
1-Imidazo[1,2-a]pyridin-6-ylacetone
|
|
C10H10N2O |
详情 |
详情
|
(VIII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(IX) |
12121 |
(Z)-4-(Dimethylamino)-3-imidazo[1,2-a]pyridin-6-yl-3-buten-2-one
|
|
C13H15N3O |
详情 |
详情
|
(X) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(XI) |
12123 |
5-Bromo-2-pyridinylamine; 5-Bromo-2-pyridinamine; 2-Amino-5-bromopyridine
|
1072-97-5 |
C5H5BrN2 |
详情 | 详情
|
(XII) |
12124 |
6-Bromoimidazo[1,2-a]pyridine
|
6188-23-4 |
C7H5BrN2 |
详情 | 详情
|
(XIII) |
12125 |
[2-Methoxy-1-(methoxycarbonyl)-2-oxoethyl]potassium
|
|
C5H7KO4 |
详情 |
详情
|
(XIV) |
12126 |
3-Imidazo[1,2-a]pyridin-6-yl-2,4-pentanedione
|
|
C12H12N2O2 |
详情 |
详情
|
(XV) |
12127 |
3-Chloro-2-methyl-1-propene; Isobutenyl chloride
|
563-47-3 |
C4H7Cl |
详情 | 详情
|
(XVI) |
12128 |
6-(2-Methyl-2-propenyl)imidazo[1,2-a]pyridine
|
|
C11H12N2 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(V) 1) The condensation of 6-bromoimidazo[1,2-a]-pyridine (I) with 2-(chloromethyl)propene (II) by means of Mg and ethyl bromide in THF gives 6-(2-methyl-2-propenyl)imidazo[1,2-a]pyridine (III), which is ozonolyzed with O3 yielding 1-(imidazo[1,2-a]-pyridin-6-yl)-2-propanone (IV). The condensation of (IV) with dimethylformamide dimethylketal (V) in hot DMF affords 4-(dimethylamino)-3-(imidazo[1,2-a]-pyridin-6-yl)-3-buten-2-one (IV), which is finally cyclized with 2-cyanoacetamide (VII) by means of sodium methoxide in hot DMF.
【1】
Miyake, K.; Ohhara, H.; Suda, S.; Toshiaki, O.; Yamanaka, M. (Eisai Co., Ltd.); 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivs.. EP 0199127; ES 8706146; ES 8708230; ES 8708231; ES 8801654; ES 8801655; JP 1986218589; US 4751227 .
|
【2】
Prous, J.; Castaner, J.; E-1020. Drugs Fut 1988, 13, 6, 514.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12124 |
6-Bromoimidazo[1,2-a]pyridine
|
6188-23-4 |
C7H5BrN2 |
详情 | 详情
|
(II) |
12127 |
3-Chloro-2-methyl-1-propene; Isobutenyl chloride
|
563-47-3 |
C4H7Cl |
详情 | 详情
|
(III) |
12128 |
6-(2-Methyl-2-propenyl)imidazo[1,2-a]pyridine
|
|
C11H12N2 |
详情 |
详情
|
(IV) |
12119 |
1-Imidazo[1,2-a]pyridin-6-ylacetone
|
|
C10H10N2O |
详情 |
详情
|
(V) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VI) |
12121 |
(Z)-4-(Dimethylamino)-3-imidazo[1,2-a]pyridin-6-yl-3-buten-2-one
|
|
C13H15N3O |
详情 |
详情
|
(VII) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(V) 2) The condensation of imidazo[1,2-a]pyridine-6-carboxaldehyde (VIII) with nitroethane (IX) by means of butylamine in refluxing ethanol gives 6-(2-nitro-1-propenyl)imidazo[1,2-a]pyridine (X), which is treated with FeCl2 and concentrated HCl in refluxing ethanol to afford propanone (IV), already obtained.
【1】
Miyake, K.; Ohhara, H.; Suda, S.; Toshiaki, O.; Yamanaka, M. (Eisai Co., Ltd.); 5-(6-Imidazo[1,2-a]pyridyl)pyridine derivs.. EP 0199127; ES 8706146; ES 8708230; ES 8708231; ES 8801654; ES 8801655; JP 1986218589; US 4751227 .
|
【2】
Prous, J.; Castaner, J.; E-1020. Drugs Fut 1988, 13, 6, 514.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
12119 |
1-Imidazo[1,2-a]pyridin-6-ylacetone
|
|
C10H10N2O |
详情 |
详情
|
(V) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VI) |
12121 |
(Z)-4-(Dimethylamino)-3-imidazo[1,2-a]pyridin-6-yl-3-buten-2-one
|
|
C13H15N3O |
详情 |
详情
|
(VII) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(VIII) |
12116 |
Imidazo[1,2-a]pyridine-6-carbaldehyde
|
|
C8H6N2O |
详情 |
详情
|
(IX) |
12117 |
Nitroethane; 1-Nitroethane
|
79-24-3 |
C2H5NO2 |
详情 | 详情
|
(X) |
12118 |
6-[(E)-2-Nitro-1-propenyl]imidazo[1,2-a]pyridine
|
|
C10H9N3O2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(IX) A preparative-scale synthetic route for T-614 has been reported:
The reaction of 4-chloro-3-nitroanisole (I) with potassium phenolate in hot DMF gives 4-phenoxy-3-nitroanisole (II), which is reduced to the corresponding 3-amino compound (III) by treatment with Fe and HCl. The reaction of (III) with mesyl chloride in pyridine affords the sulfonamide (IV), which is acylated with 2-aminoacetonitrile (V) and AlCl3 in nitrobenzene/HCl giving the 2-aminoacetophenone (VI). Formylation of (VI) at the NH2 with acetic formic anhydride yields the formamide (VII), which is demethylated with AlCl3 and NaI in acetonitrile affording the phenol (VIII). Finally, this compound is cyclized with dimethylformamide dimethylacetal in DMF.
【1】
Yoshida, C.; Tanaka, K.; Nagaki, H.; Takeno, R.; Inaba, T.; Takano, S.; Synthesis and antiinflammatory activities of 7-methanesulfonylamino-6-phenoxychromones. Antiarthritic effect of the 3-formylamino compound (T-614) in chronic inflammatory disease models. Chem Pharm Bull 2000, 48, 1, 131. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24772 |
1-chloro-4-methoxy-2-nitrobenzene
|
10298-80-3 |
C7H6ClNO3 |
详情 | 详情
|
(II) |
39674 |
4-methoxy-2-nitrophenyl phenyl ether; 4-methoxy-2-nitro-1-phenoxybenzene
|
|
C13H11NO4 |
详情 |
详情
|
(III) |
39675 |
5-methoxy-2-phenoxyphenylamine; 5-methoxy-2-phenoxyaniline
|
|
C13H13NO2 |
详情 |
详情
|
(IV) |
39676 |
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide
|
|
C14H15NO4S |
详情 |
详情
|
(V) |
39680 |
2-aminoacetonitrile
|
|
C2H4N2 |
详情 |
详情
|
(VI) |
39677 |
N-[4-(2-aminoacetyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide
|
|
C16H18N2O5S |
详情 |
详情
|
(VII) |
39678 |
N-[4-[2-(formylamino)acetyl]-5-methoxy-2-phenoxyphenyl]methanesulfonamide
|
|
C17H18N2O6S |
详情 |
详情
|
(VIII) |
39679 |
N-[4-[2-(formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]methanesulfonamide
|
|
C16H16N2O6S |
详情 |
详情
|
(IX) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(A) The protection of cytidine (I) with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (II) and dimethylformamide dimethylacetal (A) in pyridine gives the fully protected cytidine (III), which is oxidized with oxalyl chloride in DMSO/dichloromethane yielding the 2'-deoxy-2'-oxo derivative (IV). The reaction of (IV) with fluoromethyl phenyl sulfone (B) by means of diethyl chlorophosphate and lithium hexamethyldisylazide in THF affords the fluorovinyl sulfone (V) as a mixture of (E) and (Z) isomers that is separated by flash chromatography. The (Z)-isomer (V) is treated with tributyl tin hydride and AIBN in refluxing benzene to give the fluorovinyl stannane (VI), which is finally treated with KF in refluxing methanol to afford the target compound.
【1】
Donaldson, R.E. (Aventis Pharmaceuticals, Inc.); Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidine. WO 9518815 .
|
【2】
Mathews, D.P.; McCarthy, J.R.; Sabol, J.S. (Aventis Pharmaceuticals, Inc.); A process for the preparation of ribonucleotide reductase inhibitors. WO 9323414 .
|
【3】
Snyder, R.D. (Aventis Pharmaceuticals, Inc.); Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivs. and radioation or chemotherapy. WO 9601638 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(B) |
29245 |
(fluoromethyl)(dioxo)phenyl-lambda(6)-sulfane
|
20808-12-2 |
C7H7FO2S |
详情 | 详情
|
(I) |
27920 |
Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone |
65-46-3 |
C9H13N3O5 |
详情 | 详情
|
(II) |
29242 |
1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane
|
69304-37-6 |
C12H28Cl2OSi2 |
详情 | 详情
|
(III) |
29243 |
N'-[1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H44N4O6Si2 |
详情 |
详情
|
(IV) |
29244 |
N'-[1-[(6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H42N4O6Si2 |
详情 |
详情
|
(V) |
29246 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C28H42FN3O7SSi2 |
详情 |
详情
|
(VI) |
29247 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C34H64FN3O5Si2Sn |
详情 |
详情
|
(C) |
23623 |
Chlorophosphoric acid ethyl ester;Phosphorochloridic acid diethyl ester;Diethyl chlorophosphate;diethyl phosphorochloridate |
814-49-3 |
C4H10ClO3P |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(A) The protection of labeled cytidine (I) with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (II) and dimethylformamide dimethylacetal (A) in pyridine gives the fully protected cytidine (III), which is oxidized with oxalyl chloride in DMSO/dichloromethane yielding the 2'-deoxy-2'-oxo derivative (IV). The reaction of (IV) with fluoromethyl phenyl sulfone (B) by means of diethyl chlorophosphate and lithium hexamethyldisylazide in THF affords the fluorovinyl sulfone (V) as a mixture of (E) and (Z) isomers that is separated by flash chromatography. The (Z)-isomer (V) is treated with tributyl tin hydride and AIBN in refluxing benzene to give the fluorovinyl stannane (VI), which is finally treated with KF in refluxing methanol to afford the labeled target compound.
【1】
Wagner, E.R.; et al.; Radiolabeling of ribonucleotide diphosphate reductase inhibitor (E)-2'-deoxy-2'-(fluoromethylene)cytidine. Synthesis and Applications of Isotopically Labelled Compounds 1994, 659 (paper 118).
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(B) |
29245 |
(fluoromethyl)(dioxo)phenyl-lambda(6)-sulfane
|
20808-12-2 |
C7H7FO2S |
详情 | 详情
|
(I) |
27920 |
Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone |
65-46-3 |
C9H13N3O5 |
详情 | 详情
|
(I) |
45211 |
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone
|
|
C9H13N3O5 |
详情 |
详情
|
(II) |
29242 |
1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane
|
69304-37-6 |
C12H28Cl2OSi2 |
详情 | 详情
|
(III) |
29243 |
N'-[1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H44N4O6Si2 |
详情 |
详情
|
(III) |
45212 |
N'-[1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H44N4O6Si2 |
详情 |
详情
|
(IV) |
29244 |
N'-[1-[(6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H42N4O6Si2 |
详情 |
详情
|
(IV) |
45213 |
N'-[1-[(6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H42N4O6Si2 |
详情 |
详情
|
(V) |
29246 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C28H42FN3O7SSi2 |
详情 |
详情
|
(V) |
45214 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C28H42FN3O7SSi2 |
详情 |
详情
|
(VI) |
29247 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C34H64FN3O5Si2Sn |
详情 |
详情
|
(VI) |
45215 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C34H64FN3O5Si2Sn |
详情 |
详情
|
(C) |
23623 |
Chlorophosphoric acid ethyl ester;Phosphorochloridic acid diethyl ester;Diethyl chlorophosphate;diethyl phosphorochloridate |
814-49-3 |
C4H10ClO3P |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(A) The protection of cytidine (I) with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (II) and dimethylformamide dimethylacetal (A) in pyridine gives the fully protected cytidine (III), which is oxidized with oxalyl chloride in DMSO/dichloromethane yielding the 2'-deoxy-2'-oxo derivative (IV). The reaction of (IV) with labeled fluoromethyl phenyl sulfone (V) by means of diethyl chlorophosphate (B) and lithium hexamethyldisylazide in THF affords the fluorovinyl sulfone (VI) as a mixture of (E) and (Z) isomers that is separated by flash chromatography. The (Z)-isomer (VI) is treated with tributyl tin hydride and AIBN in refluxing benzene to give the fluorovinyl stannane (VII), which is finally treated with KF in refluxing methanol to afford the labeled target compound.
【1】
Wagner, E.R.; et al.; Radiolabeling of ribonucleotide diphosphate reductase inhibitor (E)-2'-deoxy-2'-(fluoromethylene)cytidine. Synthesis and Applications of Isotopically Labelled Compounds 1994, 659 (paper 118).
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(B) |
23623 |
Chlorophosphoric acid ethyl ester;Phosphorochloridic acid diethyl ester;Diethyl chlorophosphate;diethyl phosphorochloridate |
814-49-3 |
C4H10ClO3P |
详情 | 详情
|
(I) |
27920 |
Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone |
65-46-3 |
C9H13N3O5 |
详情 | 详情
|
(II) |
29242 |
1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane
|
69304-37-6 |
C12H28Cl2OSi2 |
详情 | 详情
|
(III) |
29243 |
N'-[1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H44N4O6Si2 |
详情 |
详情
|
(IV) |
29244 |
N'-[1-[(6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl]-N,N-dimethyliminoformamide
|
|
C24H42N4O6Si2 |
详情 |
详情
|
(V) |
29245 |
(fluoromethyl)(dioxo)phenyl-lambda(6)-sulfane
|
20808-12-2 |
C7H7FO2S |
详情 | 详情
|
(V) |
45218 |
fluoromethyl phenyl sulfone; (fluoromethyl)(dioxo)phenyl-lambda(6)-sulfane
|
|
C7H7FO2S |
详情 |
详情
|
(VI) |
29246 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C28H42FN3O7SSi2 |
详情 |
详情
|
(VI) |
45219 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C28H42FN3O7SSi2 |
详情 |
详情
|
(VII) |
29247 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C34H64FN3O5Si2Sn |
详情 |
详情
|
(VII) |
45220 |
1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-amino-2(1H)-pyrimidinone
|
|
C34H64FN3O5Si2Sn |
详情 |
详情
|
(VIII) |
29254 |
methyl(oxo)phenyl-lambda(4)-sulfane
|
1193-82-4 |
C7H8OS |
详情 | 详情
|
(VIII) |
45216 |
methyl phenyl sulfoxide; methyl(oxo)phenyl-lambda(4)-sulfane
|
|
C7H8OS |
详情 |
详情
|
(IX) |
29255 |
fluoromethyl phenyl sulfide
|
|
C7H7FS |
详情 |
详情
|
(IX) |
45217 |
1-[(fluoromethyl)sulfanyl]benzene; fluoromethyl phenyl sulfide
|
|
C7H7FS |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(XIII) A new synthesis of T-3761 has been described:
The esterification of 2,3,4,5-tetrafluorobenzoic acid (I) with ethyl bromide and K2CO3 in DMSO gives the corresponding ethyl ester (II), which is condensed with tert-butyl cyanoacetate (III) by means of K2CO3, yielding 4-(cyanomethyl)-2,3,5-trifluorobenzoic acid ethyl ester (V) through the intermediate (IV). The cyclopropanation of (V) with 1,2-dibromoethane and benzyltriethylammonium chloride and NaOH in water/dichloromethane affords 4-(1-cyanocyclopropyl)-2,3,5-trifluorobenzoic acid, which by treatment with H2O2 and NaOH is converted to 4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic acid (VII). Degradation of amide (VII) with Cl2 and NaOH gives the corresponding 4-aminocyclopropyl derivative (VIII), which is acetylated with acetic anhydride to the acetamide (IX). The reaction of (IX) with SOCl2 yields the acid chloride (X), which is condensed with malonic acid monoethyl ester potassium salt (XI) by means of triethylamine to afford 2-[4-(1-acetamidocyclopropyl)-2,3,5-trifluorobenzoyl]acetic acid ethyl ester (XII). The consecutive reaction of (XII) first with dimethylformamide dimethylacetal (XIII) in acetic acid and then with 2(S)-aminopropanol (XIV) gives the benzoylacrylic intermediate (XV), which, without isolation, is treated with K2CO3 in DMSO at 100 C to afford the ethyl ester of the acetylated T-3761 (XVI). Finally, this compound is deprotected by successive treatment first with ethanolic NaOH and then with hot 6N HCl.
【1】
Iino, F.; Momonoi, K.; Hayashi, K.; Todo, Y.; Kuroda, H.; Takagi, H.; Narita, H.; Takata, M.; Practical synthesis of T-3761, (S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid. Chem Pharm Bull 1994, 42, 12, 2629. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14328 |
2,3,4,5-tetrafluorobenzoic acid
|
1201-31-6 |
C7H2F4O2 |
详情 | 详情
|
(II) |
14313 |
diethyl (2S)-2-[(4-[2-[(6R)-2-(acetamido)-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate
|
|
C27H35N5O7 |
详情 |
详情
|
(III) |
14330 |
tert-Butyl cyanoacetate; tert-butyl 2-cyanoacetate
|
1116-98-9 |
C7H11NO2 |
详情 | 详情
|
(IV) |
14331 |
ethyl 4-[2-(tert-butoxy)-1-cyano-2-oxoethyl]-2,3,5-trifluorobenzoate
|
|
C16H16F3NO4 |
详情 |
详情
|
(V) |
14332 |
ethyl 4-(cyanomethyl)-2,3,5-trifluorobenzoate
|
|
C11H8F3NO2 |
详情 |
详情
|
(VI) |
14333 |
ethyl 4-(1-cyanocyclopropyl)-2,3,5-trifluorobenzoate
|
|
C13H10F3NO2 |
详情 |
详情
|
(VII) |
14334 |
4-[1-(aminocarbonyl)cyclopropyl]-2,3,5-trifluorobenzoic acid
|
|
C11H8F3NO3 |
详情 |
详情
|
(VIII) |
14335 |
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid
|
|
C10H8F3NO2 |
详情 |
详情
|
(IX) |
14336 |
4-[1-(acetamido)cyclopropyl]-2,3,5-trifluorobenzoic acid
|
|
C12H10F3NO3 |
详情 |
详情
|
(X) |
14337 |
4-[1-(acetamido)cyclopropyl]-2,3,5-trifluorobenzoyl chloride
|
|
C12H9ClF3NO2 |
详情 |
详情
|
(XI) |
14338 |
potassium 3-ethoxy-3-oxopropanoate
|
6148-64-7 |
C5H7KO4 |
详情 | 详情
|
(XII) |
14339 |
ethyl 3-[4-[1-(acetamido)cyclopropyl]-2,3,5-trifluorophenyl]-3-oxopropanoate
|
|
C16H16F3NO4 |
详情 |
详情
|
(XIII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XIV) |
14341 |
L-Alaninol; (2S)-2-Amino-1-propanol; L-(+)-Alaninol
|
2749-11-3 |
C3H9NO |
详情 | 详情
|
(XV) |
14342 |
ethyl (E)-2-[4-[1-(acetamido)cyclopropyl]-2,3,5-trifluorobenzoyl]-3-[[(1S)-2-hydroxy-1-methylethyl]amino]-2-propenoate
|
|
C20H23F3N2O5 |
详情 |
详情
|
(XVI) |
14343 |
ethyl (3S)-10-[1-(acetamido)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C20H21FN2O5 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(XIV) A new synthesis for T-3761 has been described:
The esterification of 2,3,4,5-tetrafluorobenzoic acid (I) with SOCl2 and ethanol gives ethyl 2,3,4,5-tetrafluorobenzoate (II), which is condensed with di-tert-butyl malonate (III) by means of NaH in DMF and decarboxylated with HCl/trifluoroacetic acid to 4-(carboxymethyl)-2,3,5-trifluorobenzoic acid ethyl ester (IV). Esterification of (IV) with diphenyldiazomethane in ether affords the corresponding ester (V), which is methylenated with bis(dimethylamino)methane (VI) and acetic anhydride in DMSO to give 4-[1-(diphenylmethoxycarbonyl)vinyl]-2,3,5-trifluorobenzoic acid ethyl ester (VII). The cyclopropanation of (VII) with trimethylsulfoxonium iodide and potassium tert-butoxide [(CH3)2SO=CH2] yields the cyclopropane compound (VIII), which is selectively hydrolyzed with trifluoroacetic acid to 4-(1-carboxycyclopropyl)-2,3,5-trifluorobenzoic acid ethyl ester (IX). The decarboxylative amination of (IX) with ethyl chloroformate, sodium azide and benzyl alcohol gives 4-[1-(benzyloxycarbonylamino)cyclopropyl]-2,3,5-trifluorobenzoic acid ethyl ester (X), which is saponified with NaOH in dioxane/ethanol to the corresponding acid (XI). The condensation of (XI) with the magnesium salt of malonic acid mono-tert-butyl ester (XII) by means of carbonyldiimidazole (Im2CO) in THF affords the benzoylacetic ester (XIII), which is treated first with dimethylformamide dimethylacetal (XIV) in refluxing benzene and then with 2-amino-1-propanol (XV) to yield 2-[4-[1-(benzyloxycarbonylamino)cyclopropyl]-2,3,5-trifluorobenzoyl]-3-(2-hydroxy-1-methylethylamino)-2-propenoic acid ethyl ester (XVI). The cyclization of (XVI) by means of K2CO3 in hot DMF gives the pyridobenzoxazine (XVII), which is saponified with NaOH in ethanol/dioxane to the corresponding free acid (XVIII). Finally, the amino group of (XVIII) is deprotected by hydrogenation with H2 over Pd/C
【1】
Fukuoka, Y.; Nitta, J.; Todo, Y.; Nishida, N.; Saikawa, I.; Narita, H.; Miyajima, M.; Yamashiro, Y.; Pyridonecarboxylic acids as antibacterial agents. VIII. Synthesis and structure-activity relationship of 7-(1-aminocyclopropyl)-4-oxo-1,8-naphthyridine-3-carboxylic acids and 7-(1-aminocyclopropyl)-4-oxoquinoline-3-carboxylic acids. Chem Pharm Bull 1994, 42, 10, 2063. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14328 |
2,3,4,5-tetrafluorobenzoic acid
|
1201-31-6 |
C7H2F4O2 |
详情 | 详情
|
(II) |
14313 |
diethyl (2S)-2-[(4-[2-[(6R)-2-(acetamido)-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate
|
|
C27H35N5O7 |
详情 |
详情
|
(III) |
14346 |
di(tert-butyl) malonate; Di-tert-butyl malonate
|
541-16-2 |
C11H20O4 |
详情 | 详情
|
(IV) |
14315 |
2-[4-(ethoxycarbonyl)-2,3,6-trifluorophenyl]acetic acid
|
|
C11H9F3O4 |
详情 |
详情
|
(V) |
14316 |
ethyl 4-[2-(benzhydryloxy)-2-oxoethyl]-2,3,5-trifluorobenzoate
|
|
C24H19F3O4 |
详情 |
详情
|
(VI) |
14349 |
N,N,N,N-tetramethylmethanediamine; tetramethylmethylenediamine;bis(dimethylamino)methane; N-[(dimethylamino)methyl]-N,N-dimethylamine |
51-80-9 |
C5H14N2 |
详情 | 详情
|
(VII) |
14318 |
ethyl 4-[1-[(benzhydryloxy)carbonyl]vinyl]-2,3,5-trifluorobenzoate
|
|
C25H19F3O4 |
详情 |
详情
|
(VIII) |
14319 |
ethyl 4-[1-[(benzhydryloxy)carbonyl]cyclopropyl]-2,3,5-trifluorobenzoate
|
|
C26H21F3O4 |
详情 |
详情
|
(IX) |
14320 |
1-[4-(ethoxycarbonyl)-2,3,6-trifluorophenyl]cyclopropanecarboxylic acid
|
|
C13H11F3O4 |
详情 |
详情
|
(X) |
14353 |
benzyl N-[1-(4-acetyl-2,3,6-trifluorophenyl)cyclopropyl]carbamate
|
|
C19H16F3NO3 |
详情 |
详情
|
(XI) |
14322 |
4-(1-[[(benzyloxy)carbonyl]amino]cyclopropyl)-2,3,5-trifluorobenzoic acid
|
|
C18H14F3NO4 |
详情 |
详情
|
(XII) |
14355 |
Bis(malonic acid monoethyl ester) magnesium salt
|
|
C10H14MgO8 |
详情 |
详情
|
(XIII) |
14323 |
ethyl 3-[4-(1-[[(benzyloxy)carbonyl]amino]cyclopropyl)-2,3,5-trifluorophenyl]-3-oxopropanoate
|
|
C22H20F3NO5 |
详情 |
详情
|
(XIV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XV) |
14358 |
2-amino-1-propanol; DL-Alaninol
|
6168-72-5 |
C3H9NO |
详情 | 详情
|
(XVI) |
14359 |
ethyl (E)-2-[4-(1-[[(benzyloxy)carbonyl]amino]cyclopropyl)-2,3,5-trifluorobenzoyl]-3-[(2-hydroxy-1-methylethyl)amino]-2-propenoate
|
|
C26H27F3N2O6 |
详情 |
详情
|
(XVII) |
14360 |
ethyl 10-(1-[[(benzyloxy)carbonyl]amino]cyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C26H25FN2O6 |
详情 |
详情
|
(XVIII) |
14361 |
10-(1-[[(benzyloxy)carbonyl]amino]cyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
|
|
C24H21FN2O6 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) Reaction of 4-acetylpyridine (I) with hot dimethylformamide dimethyl acetal (II) gives the enamino ketone (III), which is then condensed with (3-amino-1H-pyrazol-4-yl)(2-pyridyl)methanone (IV) in boiling acetic acid.
Intermediate (IV), (3-amino-1H-pyrazol-4-yl)(2-pyrid-yl)methanone, is obtained by condensation of 3-oxo-3-(2-pyridyl)propionitrile (V) with dimethylformamide dimethyl acetal (II) to provide 2-(dimethylaminomethylene)-3-oxo-3-(2-pyridyl)propionitrile (VI), which is finally coupled with aminoguanidine nitrate (VII) by means of 10N NaOH in refluxing EtOH
【1】
Castaner, J.; Silvestre, J.S.; Chilman-Blair, K.; Ocinaplon. Drugs Fut 2003, 28, 2, 115-120.
|
【2】
Tomcufcik, A.S.; Dusza, J.P. (Wyeth); (3-Amino-1H-pyrazol-4-yl)(aryl)methanones. EP 0129846; JP 1985013764; US 4900836 .
|
【3】
Dusza, J.P.; Tomcufcik, A.S.; Albright, J.D. (Wyeth); Aryl and heteroaryl 7-(aryl and heteroaryl)-pyrazolo[1,5-a]pyrimidin-3-ylmethanones. DE 3422844; EP 0129847; JP 1985019788 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59510 |
4-Acetylpyridine; Methyl 4-pyridyl ketone
|
1122-54-9 |
C7H7NO |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
59511 |
(E)-3-(dimethylamino)-1-(4-pyridinyl)-2-propen-1-one
|
|
C10H12N2O |
详情 |
详情
|
(IV) |
59512 |
(3-amino-1H-pyrazol-4-yl)(2-pyridinyl)methanone
|
|
C9H8N4O |
详情 |
详情
|
(V) |
59513 |
3-oxo-3-(2-pyridinyl)propanenitrile
|
|
C8H6N2O |
详情 |
详情
|
(VI) |
59514 |
(E)-3-(dimethylamino)-2-(2-pyridinylcarbonyl)-2-propenenitrile
|
|
C11H11N3O |
详情 |
详情
|
(VII) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(IV) The title compound has been obtained by several related ways:
The reaction of 2-chloro-3-nitropyridine (I) with methylboronic acid by means of Pd(PPh3)4 and K2CO3 in hot dioxane gives 2-methyl-3-nitropyridine (III), which is condensed with dimethylformamide dimethylacetal (IV) to yield 2-[2-(dimethylamino)vinyl]-3-nitropyridine (V). The oxidation of (V) by means of NaIO4 affords 3-nitropyridine-2-carbaldehyde (VI), which is condensed with semicarbazide (VII) to provide the corresponding semicarbazone (VIII). Finally, the nitro group of (VIII) is reduced with SnCl2 or Na2S to furnish the target 3-aminopyridine-2-carbaldehyde semicarbazone.
2-Methyl-3-nitropyridine (III) can also be obtained by condensation of 2-chloro-3-nitropyridine (I) with diethyl malonate (II) by means of Na, followed by decarboxylative hydrolysis with H2SO4 at 125 C.
The direct oxidation of 2-methyl-3-nitropyridine (III) with SeO2 in dioxane gives carbaldehyde (VI), which is treated with ethyleneglycol (IX) and Ts-OH to yield the cyclic acetal (X). The reduction of (X) with H2 over Pd/C in ethanol affords 3-aminopyridine-2-carbaldehyde ethylene ketal (XI), which is treated with semicarbazide (VI) and HCl to afford the target 3-aminopyridine-2-carbaldehyde semicarbazone.
The condensation of 2-chloro-3-nitropyridine (I) with tributyl vinyl tin (XII) Pd(PPh3)4 and PPH3 in refluxing toluene gives 3-nitro-2-vinylpyridine (XIII), which is oxidized with O3 and Me2S in methanol to yield 3-nitropyridine-2-carbaldehyde (VI). This compound is condensed with semicarbazide (VII) and reduced to the target compound as already described.
【1】
Li, J.; et al.; Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-Amino-4-methylpyridine-2-carboxaldehyde-thiosemicarbazone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs. Curr Med Chem 2001, 8, 2, 121. |
【2】
Niu, C.; et al.; Synthesis of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP). Tetrahedron 1998, 54, 23, 6311.
|
【3】
Liu, M-C.; et al.; Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone. J Med Chem 1992, 35, 20, 3672.
|
【4】
Sartorelli, A.C.; Lin, T.-S. (Yale University); 2-Formylpyridine thiosemicarbazone derivs., their preparation and their use as antitumor agents. EP 0570294; JP 1994128230; US 5281715; US 5721259 .
|
【5】
Doyle, T.W.; Li, J.; Chen, S.-H.; Li, X.; Niu, C.-S. (Vion Pharmaceuticals, Inc.); Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP. US 5869676; WO 9851670 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10321 |
2-Chloro-3-nitropyridine
|
5470-18-8 |
C5H3ClN2O2 |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
54410 |
2-methyl-3-nitropyridine
|
18699-87-1 |
C6H6N2O2 |
详情 | 详情
|
(IV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(V) |
54411 |
(E)-N,N-dimethyl-2-(3-nitro-2-pyridinyl)-1-ethenamine; N,N-dimethyl-N-[(E)-2-(3-nitro-2-pyridinyl)ethenyl]amine
|
|
C9H11N3O2 |
详情 |
详情
|
(VI) |
54414 |
3-nitro-2-pyridinecarbaldehyde
|
10261-94-6 |
C6H4N2O3 |
详情 | 详情
|
(VII) |
12954 |
1-Hydrazinecarbothioamide; Thiosemicarbazide
|
79-19-6 |
CH5N3S |
详情 | 详情
|
(VIII) |
54415 |
2-[(E)-(3-nitro-2-pyridinyl)methylidene]-1-hydrazinecarbothioamide
|
|
C7H7N5O2S |
详情 |
详情
|
(IX) |
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(X) |
54413 |
2-(1,3-dioxolan-2-yl)-3-nitropyridine
|
|
C8H8N2O4 |
详情 |
详情
|
(XI) |
54412 |
2-(1,3-dioxolan-2-yl)-3-pyridinylamine; 2-(1,3-dioxolan-2-yl)-3-pyridinamine
|
|
C8H10N2O2 |
详情 |
详情
|
(XII) |
54417 |
3,3-dibutyl-1-heptene
|
|
C15H30 |
详情 |
详情
|
(XIII) |
54416 |
3-nitro-2-vinylpyridine
|
|
C7H6N2O2 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(II) The condensation of 1-(3-pyridyl)ethanone (I) with dimethylformamide dimethylacetal (II) gives 3-(dimethylamino)-1-(3-pyridyl)-2-propen-1-one (III), which is cyclized with 1-(2-methyl-5-nitrophenyl)guanidine (IV) [obtained by reaction of 2-methyl-5-nitroaniline (V) with cyanamide (VI)] in refluxing isopropanol to yield the pyrimidine derivative (VII). Reduction of the nitro group of (VII) with H2 over Pd/C in THF affords the corresponding amino compound (VIII), which is finally condensed with 4-(4-methylpiperazin-1-ylmethyl)benzoyl chloride (IV) in pyridine.
【1】
Castaner, J.; Fernandez, R.; de Bree, F.; Sorbera, L.A.; Imatinib Mesilate. Drugs Fut 2001, 26, 6, 545.
|
【2】
Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N.B.; Zimmermann, J.; Potent and selective inhibitors of the Abl-kinase: Phenylaminopyrimidine (PAP) derivatives. Bioorg Med Chem Lett 1997, 7, 2, 187.
|
【3】
Zimmermann, J. (Novartis AG); Pyrimidine derivs. and process for their preparation. EP 0564409; JP 1994087834; US 5521184 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12027 |
1-(3-Pyridinyl)-1-ethanone; 1-(3-Pyridinyl)ethanone
|
350-03-8 |
C7H7NO |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
47516 |
(E)-3-(dimethylamino)-1-(3-pyridinyl)-2-propen-1-one
|
123367-26-0 |
C10H12N2O |
详情 | 详情
|
(IV) |
47517 |
N-(2-methyl-5-nitrophenyl)guanidine
|
152460-07-6 |
C8H10N4O2 |
详情 | 详情
|
(V) |
47518 |
2-Amino-4-nitrotoluene; 5-Nitro-o-toluidine; 4-Nitro-2-aminotoluene; 2-methyl-5-nitrophenylamine; 2-methyl-5-nitroaniline
|
99-55-8 |
C7H8N2O2 |
详情 | 详情
|
(VI) |
19648 |
Cyanamide
|
420-04-2 |
CH2N2 |
详情 | 详情
|
(VII) |
47519 |
N-(2-methyl-5-nitrophenyl)-N-[4-(3-pyridinyl)-2-pyrimidinyl]amine; N-(2-methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-pyrimidinamine
|
152460-09-8 |
C16H13N5O2 |
详情 | 详情
|
(VIII) |
47520 |
4-methyl-N(3)-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine; N-(5-amino-2-methylphenyl)-N-[4-(3-pyridinyl)-2-pyrimidinyl]amine
|
152460-10-1 |
C16H15N5 |
详情 | 详情
|
(IX) |
47521 |
4-[(4-methyl-1-piperazinyl)methyl]benzoyl chloride
|
148077-69-4 |
C13H17ClN2O |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(II) 2',4',6'-Trimethoxyacetophenone (I) was condensed with dimethylformamide dimethylacetal (II) in refluxing DMF to afford the enamino ketone (III). Subsequent cyclization of (III) with N1-dicyclopropylmethyl-N1-propyl-guanidine hydrochloride (IV) in the presence of t-BuOK produced the target pyrimidine.
【1】
McCarthy, J.R.; Xie, Y.F.; Whitten, J.P.; Webb, T.R.; Chen, C.; Ramphal, J.Y.; Grigoriadis, D.E.; Dagnino, R. Jr.; Huang, C.Q.; Liu, Z. (Neurocrine Biosciences Inc.); Amino-substd. thiadiazoles, pyrimidines, triazines or triazoles useful as CTF receptor antagonists. EP 0846108; JP 1999507358; US 5795905; WO 9639400 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35623 |
1-(2,4,6-trimethoxyphenyl)-1-ethanone
|
832-58-6 |
C11H14O4 |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
35624 |
(E)-3-(dimethylamino)-1-(2,4,6-trimethoxyphenyl)-2-propen-1-one
|
|
C14H19NO4 |
详情 |
详情
|
(IV) |
35625 |
N-(dicyclopropylmethyl)-N-propylguanidine
|
|
C11H21N3 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) Condensation of 3-pyridylacetonitrile (I) with dimethyl-formamide dimethylacetal (II) afforded dimethylaminomethylene compound (III), which was cyclized to isoxazole (IV) by treatment with hydroxylamine.HCl in AcOH at 100 C. Quaternization with iodomethane provided pyridinium salt (V), and subsequent reduction with NaBH4 in MeOH produced tetrahydropyridine (VI). Then, methylation with iodomethane in the presence of KOH gave a mixture of monomethylated (VII) and dimethylated (VIII) compounds, which were separated by column chromatography. Finally, the major methylamino compound (VII) was converted to the oxalate salt.
【1】
Olesen, P.H.; Swedberg, M.D.B.; Rimvall, K.; 3-(5-Alkylamino-4-isoxazolyl)-1,2,5,6-tetrahydropyridines: A novel class of central nicotinic receptor ligands. Bioorg Med Chem 1998, 6, 9, 1623.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18579 |
2-(3-pyridinyl)acetonitrile
|
6443-85-2 |
C7H6N2 |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
18581 |
(Z)-3-(dimethylamino)-2-(3-pyridinyl)-2-propenenitrile
|
|
C10H11N3 |
详情 |
详情
|
(IV) |
18582 |
4-(3-pyridinyl)-5-isoxazolamine; 4-(3-pyridinyl)-5-isoxazolylamine
|
|
C8H7N3O |
详情 |
详情
|
(V) |
18583 |
3-(5-amino-4-isoxazolyl)-1-methylpyridinium iodide
|
|
C9H10IN3O |
详情 |
详情
|
(VI) |
18584 |
4-(1-methyl-1,2,5,6-tetrahydro-3-pyridinyl)-5-isoxazolamine; 4-(1-methyl-1,2,5,6-tetrahydro-3-pyridinyl)-5-isoxazolylamine
|
|
C9H13N3O |
详情 |
详情
|
(VII) |
18585 |
N-methyl-N-[4-(1-methyl-1,2,5,6-tetrahydro-3-pyridinyl)-5-isoxazolyl]amine; N-methyl-4-(1-methyl-1,2,5,6-tetrahydro-3-pyridinyl)-5-isoxazolamine
|
|
C10H15N3O |
详情 |
详情
|
(VIII) |
18586 |
N,N-dimethyl-N-[4-(1-methyl-1,2,5,6-tetrahydro-3-pyridinyl)-5-isoxazolyl]amine; N,N-dimethyl-4-(1-methyl-1,2,5,6-tetrahydro-3-pyridinyl)-5-isoxazolamine
|
|
C11H17N3O |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(XIII) The methylation of 2,6-difluorophenol (I) with methyl iodide and K2CO3 in DMF gives 2,6-difluoroanisole (II), which by treatment with butyllithium and CO2 yields 2,4-difluoro-3-methoxybenzoic acid (III). The methylation of (III) with diazomethane in ether affords the methyl ester (IV), which by reaction with BBr3 in dichloromethane results in 2,4-difluoro-3-hydroxybenzoic acid methyl ester (V). The alkylation of (V) with chlorodifluoromethane and K2CO3 in DMF gives 3-(difluoromethoxy)-2,4-difluorobenzoic acid methyl ester (VI), which is treated with sodium azide in DMSO, yielding the azido derivative (VII). The reduction of (VII) with H2 over Pd/C in ethanol affords 3-amino-2,4-difluorobenzoic acid methyl ester (VIII), which is hydrolyzed with NaOH in ethanol, giving the free acid (IX). The reaction of (IX) with NaNO2 and HBr yields 4-bromo-3-(difluoromethoxy)-2-fluorobenzoic acid (X), which is condensed with the magnesium salt of malonic acid monoethyl ester (XI) by means of CDI in THF, affording the 3-oxopropionate (XII). The reaction of (XII) with dimethylformamide dimethylacetal (XIII) and cyclopropylamine (XIV) by means of acetic anhydride in dichloromethane gives the 3-(cyclopropylamino)acrylate (XV), which is cyclized by means of K2CO3 in hot DMSO, yielding quinolone (XVI). The condensation of (XVI) with the isoindolylboronic acid derivative (XVII) - obtained by reaction of 5-bromo-1(R)-methyl-2-tritylisoindoline (XIX) with triisopropyl borate and butyllithium in THF - by means of bis(triphenylphosphine)palladium(II) chloride as catalyst in refluxing toluene affords the protected compound (XVIII), which is finally deprotected with HCl in ethanol.
【1】
Castañer, J.; Rabasseda, X.; Graul, A.; T-3811ME. Drugs Fut 1999, 24, 12, 1324.
|
【2】
Todo, Y.; Hayashi, K.; Takahata, M.; Watanabe, Y.; Narita, H. (Toyama Chemical Co., Ltd.); Quinolonecarboxylic acid derivs. or salts thereof.. EP 0882725; US 6025370; WO 9729102 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30619 |
2,6-difluorophenol
|
28177-48-2 |
C6H4F2O |
详情 | 详情
|
(II) |
30620 |
2,6-difluorophenyl methyl ether; 1,3-difluoro-2-methoxybenzene
|
|
C7H6F2O |
详情 |
详情
|
(III) |
30621 |
2,4-difluoro-3-methoxybenzoic acid
|
178974-97-5 |
C8H6F2O3 |
详情 | 详情
|
(IV) |
30622 |
methyl 2,4-difluoro-3-methoxybenzoate
|
|
C9H8F2O3 |
详情 |
详情
|
(V) |
30623 |
methyl 2,4-difluoro-3-hydroxybenzoate
|
|
C8H6F2O3 |
详情 |
详情
|
(VI) |
30624 |
methyl 3-(difluoromethoxy)-2,4-difluorobenzoate
|
|
C9H6F4O3 |
详情 |
详情
|
(VII) |
30625 |
methyl 4-azido-3-(difluoromethoxy)-2-fluorobenzoate
|
|
C9H6F3N3O3 |
详情 |
详情
|
(VIII) |
30626 |
methyl 4-amino-3-(difluoromethoxy)-2-fluorobenzoate
|
|
C9H8F3NO3 |
详情 |
详情
|
(IX) |
30627 |
4-amino-3-(difluoromethoxy)-2-fluorobenzoic acid
|
|
C8H6F3NO3 |
详情 |
详情
|
(X) |
30628 |
4-bromo-3-(difluoromethoxy)-2-fluorobenzoic acid
|
|
C8H4BrF3O3 |
详情 |
详情
|
(XI) |
14338 |
potassium 3-ethoxy-3-oxopropanoate
|
6148-64-7 |
C5H7KO4 |
详情 | 详情
|
(XII) |
30629 |
ethyl 3-[4-bromo-3-(difluoromethoxy)-2-fluorophenyl]-3-oxopropanoate
|
|
C12H10BrF3O4 |
详情 |
详情
|
(XIII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XIV) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(XV) |
30630 |
ethyl (Z)-2-[4-bromo-3-(difluoromethoxy)-2-fluorobenzoyl]-3-(cyclopropylamino)-2-propenoate
|
|
C16H15BrF3NO4 |
详情 |
详情
|
(XVI) |
30631 |
ethyl 7-bromo-1-cyclopropyl-8-(difluoromethoxy)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H14BrF2NO4 |
详情 |
详情
|
(XVII) |
30632 |
(1R)-1-methyl-2-trityl-2,3-dihydro-1H-isoindol-5-ylboronic acid
|
|
C28H26BNO2 |
详情 |
详情
|
(XVIII) |
30633 |
ethyl 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C44H38F2N2O4 |
详情 |
详情
|
(XIX) |
30634 |
(1R)-5-bromo-1-methyl-2-trityl-2,3-dihydro-1H-isoindole
|
|
C28H24BrN |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) The reaction of 2-amino-5-nitrobenzoic acid (I) with N,N-dimethylformamide dimethylacetal (II) by heating at 100 C gives the formamidine (III), which is cyclized with 3-bromoaniline (IV) in refluxing acetic acid yielding 4-(3-bromophenyl)-6-nitroquinazoline (V). The reduction of (V) with Fe and acetic acid affords the amine (VI), which is finally acylated with 2-butynoic acid by means of isobutyl chloroformate and N-methylmorpholine in THF.
【1】
Wissner, A.; Johnson, B.D.; Floyd, M.B. Jr.; Kitchen, D.B. (American Cyanamid Co.); 4-Aminoquinazoline EGFR inhibitors. EP 0787722; US 5760041 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23218 |
2-amino-5-nitrobenzonitrile
|
17420-30-3 |
C7H5N3O2 |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
23219 |
N'-(2-cyano-4-nitrophenyl)-N,N-dimethyliminoformamide
|
|
C10H10N4O2 |
详情 |
详情
|
(IV) |
19136 |
3-bromoaniline; 3-bromophenylamine; 3-bromobenzenamine
|
591-19-5 |
C6H6BrN |
详情 | 详情
|
(V) |
23221 |
N-(3-bromophenyl)-N-(6-nitro-4-quinazolinyl)amine; N-(3-bromophenyl)-6-nitro-4-quinazolinamine
|
|
C14H9BrN4O2 |
详情 |
详情
|
(VI) |
23222 |
N(4)-(3-bromophenyl)-4,6-quinazolinediamine; N-(6-amino-4-quinazolinyl)-N-(3-bromophenyl)amine
|
|
C14H11BrN4 |
详情 |
详情
|
(VII) |
10938 |
2-Butynoic acid
|
590-93-2 |
C4H4O2 |
详情 | 详情
|
合成路线24
该中间体在本合成路线中的序号:
(III) The cyclization of acetyl cyclopropane (I) with 2-nitroacetamide (II) and formamide dimethylacetal (III) by means of p-tolulenesulfonic acid gives the nitro-pyridinone (IV) (1), which is reduced with H2 over Pd/C affording 3-amino-6-propylpyridin-2(1H)-one (V). The protection of the amino group of (V) with benzyl chloroformate affords the carbamate (VI), which is condensed with tert-butyl bromoacetate (VII) by means of NaH in THF giving substituted acetate ester (VIII). The deprotection of (VIII) by hydrogenolysis with H2 over Pd/C in ethyl acetate yields intermediate (IX) with a free amino group, which is treated with benzylsulfonyl chloride (X) and pyridine to afford the sulfonamide (XI). Hydrolysis of the ester group of (XI) with HCl in ethyl acetate gives the carboxylic acid (XII), which is condensed with the pyridylmethylamine (XIII) by means of EDC and HOBT to afford the carboxamide (XIV). Finally, this compound is deprotected with HCl as usual.
【1】
C6 modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption. Bioorg Med Chem Lett 1998, 8, 13, 1719.
|
【2】
Sanderson, P.E.; Naylor-Olsen, A.M.; Dyer, D.L.; Vacca, J.P.; Isaacs, R.C.A.; Dorsey, B.D.; Fraley, M.E. (Merck & Co., Inc.); Pyridinone-thrombin inhibitors. EP 0835109; JP 1999508558; WO 9701338 .
|
【3】
Dorsey, B.D.; Isaacs, R.C.A.; Sanderson, P.E.; Dyer, D.L.; Naylor-Olsen, A.M.; Fraley, M.E.; Vacca, J.P. (Merck & Co., Inc.); Pyridinone thrombin inhibitors. US 5668289 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(I) |
12435 |
Acetylcyclopropane; 1-Cyclopropyl-1-ethanone; Cyclopropylmethylketone
|
765-43-5 |
C5H8O |
详情 | 详情
|
(II) |
27209 |
2-nitroacetamide
|
|
C2H4N2O3 |
详情 |
详情
|
(III) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(IV) |
27210 |
6-cyclopropyl-3-nitro-2(1H)-pyridinone
|
|
C8H8N2O3 |
详情 |
详情
|
(V) |
27211 |
3-amino-6-propyl-2(1H)-pyridinone
|
|
C8H12N2O |
详情 |
详情
|
(VI) |
27212 |
benzyl 2-oxo-6-propyl-1,2-dihydro-3-pyridinylcarbamate
|
|
C16H18N2O3 |
详情 |
详情
|
(VII) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(VIII) |
27213 |
tert-butyl 2-[3-[[(benzyloxy)carbonyl]amino]-2-oxo-6-propyl-1(2H)-pyridinyl]acetate
|
|
C22H28N2O5 |
详情 |
详情
|
(IX) |
27214 |
tert-butyl 2-[3-amino-2-oxo-6-propyl-1(2H)-pyridinyl]acetate
|
|
C14H22N2O3 |
详情 |
详情
|
(X) |
27215 |
phenylmethanesulfenyl chloride
|
|
C7H7ClS |
详情 |
详情
|
(XI) |
27216 |
tert-butyl 2-[3-[(benzylsulfonyl)amino]-2-oxo-6-propyl-1(2H)-pyridinyl]acetate
|
|
C21H28N2O5S |
详情 |
详情
|
(XII) |
27217 |
2-[3-[(benzylsulfonyl)amino]-2-oxo-6-propyl-1(2H)-pyridinyl]acetic acid
|
|
C17H20N2O5S |
详情 |
详情
|
(XIII) |
27218 |
tert-butyl 5-(aminomethyl)-6-methyl-2-pyridinylcarbamate
|
|
C12H19N3O2 |
详情 |
详情
|
(XIV) |
27219 |
tert-butyl 5-[([2-[3-[(benzylsulfonyl)amino]-2-oxo-6-propyl-1(2H)-pyridinyl]acetyl]amino)methyl]-6-methyl-2-pyridinylcarbamate
|
|
C29H37N5O6S |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(II) The condensation of pyruvic aldehyde dimethyl acetal (I) with dimethylformamide dimethyl acetal (II) afforded ketoenamine (III), which was condensed with N-methyl guanidine (IV) to give pyrimidine (V). Acid hydrolysis of the acetal function of (V) yielded pyrimidine carboxaldehyde (VI), which was converted to the imine (VIII) by treatment with 1-Boc-4-aminopiperidine (VII). Isonitrile (XII) was prepared by condensation of 4-fluorobenzaldehyde (IX) with formamide and p-thiocresol (X), followed by dehydration of the resulting formamide (XI) by means of POCl3 and Et3N. Reaction of isonitrile (XII) with imine (VIII) in the presence of 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) produced imidazole (XIII). Finally, acid deprotection of the Boc group of (XIII) provided the title compound.
【1】
Adams, J.L.; Gallagher, T.F.; Garigipati, R.S.; Boehm, J.C.; Sisko, J.; Peng, Z.-Q.; Lee, J.C.-L. (SmithKline Beecham plc); Certain 1,4,5-tri-substd. imidazole cpds. useful as cytokine. EP 0809499; JP 1998512555; US 5593992; WO 9621452 .
|
【2】
Garigipati, R.S.; Adams, J.L.; Boehm, J.C. (SmithKline Beecham Corp.); Pyridyl imidazole cpds. and compsns.. US 5670527 .
|
【3】
Adams, J.L.; Boehm, J.C.; Imidazole cpds., use and process of making. US 5593991 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25433 |
1,1-dimethoxyacetone
|
6342-56-9 |
C5H10O3 |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
25434 |
(E)-4-(dimethylamino)-1,1-dimethoxy-3-buten-2-one
|
|
C8H15NO3 |
详情 |
详情
|
(IV) |
28411 |
N-Methylguanidine
|
598-12-9 |
C2H7N3 |
详情 | 详情
|
(V) |
28412 |
4-(dimethoxymethyl)-N-methyl-2-pyrimidinamine
|
|
C8H13N3O2 |
详情 |
详情
|
(VI) |
28413 |
2-(methylamino)-4-pyrimidinecarbaldehyde
|
|
C6H7N3O |
详情 |
详情
|
(VII) |
28414 |
4-Amino-1-N-Boc-piperidine; tert-butyl 4-amino-1-piperidinecarboxylate; N-Boc-4-aminopiperidine
|
87120-72-7 |
C10H20N2O2 |
详情 | 详情
|
(VIII) |
28415 |
tert-butyl 4-([(Z)-[2-(methylamino)-4-pyrimidinyl]methylidene]amino)-1-piperidinecarboxylate
|
|
C16H25N5O2 |
详情 |
详情
|
(IX) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(X) |
25437 |
4-methylphenylhydrosulfide
|
106-45-6 |
C7H8S |
详情 | 详情
|
(XI) |
25438 |
(4-fluorophenyl)[(4-methylphenyl)sulfanyl]methylformamide
|
|
C15H14FNOS |
详情 |
详情
|
(XII) |
28416 |
4-Fluoro-alpha-(4-methylphenylsulfanyl)benzyl isocyanide
|
|
C15H12FNS |
详情 |
详情
|
(XIII) |
28417 |
tert-butyl 4-[4-(4-fluorophenyl)-5-[2-(methylamino)-4-pyrimidinyl]-1H-imidazol-1-yl]-1-piperidinecarboxylate
|
|
C24H29FN6O2 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(II) The reaction of 3-methoxybenzoylacetone (I) with dimethylformamide dimethylacetal (II) gives the dimethylaminomethylene derivative (III), which is cyclized with 2-cyanoacetamide (IV) by means of sodium ethoxide in ethanol yielding the pyridinone (V). The condensation of (V) with dimethylformamide dimethylacetal (II) affords the dimethylaminovinylpyridinone (VI), which is cyclized by means of ammonium acetate in DMF providing the 1,6-naphthyridine (VII). The hydrolysis of the cyano group of (VII) with NaOH gives the corresponding carboxylic acid (VIII), which is finally cyclized with N-hydroxyacetamidine (IX) by means of carbonydimidazole (CDI).
【1】
Odai, O.; et al.; Synthesis and pharmacological evaluation of novel 3-oxadiazolyl-1,6-naphthyridines as a new class of potential cognitive enhancers. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.256. |
【2】
Masumoto, K.; et al.; Structure-activity relationships and cognition-enhancing actions of novel 1,6-naphthyridine derivatives with benzodiazepine receptor inverse agonists activities. Symp Med Chem 1998, Abst 2-P-10.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25984 |
1-(3-methoxyphenyl)-1,3-butanedione
|
|
C11H12O3 |
详情 |
详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
25985 |
2-[(E)-(dimethylamino)methylidene]-1-(3-methoxyphenyl)-1,3-butanedione
|
|
C14H17NO3 |
详情 |
详情
|
(IV) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(V) |
25986 |
5-(3-methoxybenzoyl)-6-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile
|
|
C15H12N2O3 |
详情 |
详情
|
(VI) |
25987 |
6-[(E)-2-(dimethylamino)ethenyl]-5-(3-methoxybenzoyl)-2-oxo-1,2-dihydro-3-pyridinecarbonitrile
|
|
C18H17N3O3 |
详情 |
详情
|
(VII) |
25988 |
5-(3-methoxyphenyl)-2-oxo-1,2-dihydro[1,6]naphthyridine-3-carbonitrile
|
|
C16H11N3O2 |
详情 |
详情
|
(VIII) |
25989 |
5-(3-methoxyphenyl)-2-oxo-1,2-dihydro[1,6]naphthyridine-3-carboxylic acid
|
|
C16H12N2O4 |
详情 |
详情
|
(IX) |
25990 |
N-hydroxyethanimidamide
|
|
C2H6N2O |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(XVII) Reaction of 2-hydroxy-4-methoxypyridine-3-carbonitrile (X) with 85% phosphoric acid at 180 C gives 2,4-dihydroxypyridine (XI), which is nitrated with HNO3 in hot acetic acid to yield 2,4-dihydroxy-3-nitropyridine (XII). The reaction of (XII) with POCl3 in hot toluene affords 4-chloro-3-nitropyridin-2(1H)-one (XIII), which is condensed with the previously described amine (II) by means of DIEA in isopropanol to afford the aminopyridinol (XIV). Chlorination of (XIV) with POCl3 in toluene gives the previously described 4-amino-2-chloro-3-nitropyridine derivative (III), which is condensed with the described cyclopentanecarboxamide (IV) by means of K2CO3 in toluene, yielding the already known 2,4-diamino-3-nitropyridine (V). The reduction of (V) with ammonium formate over Pt/C or with Zn and ammonium acetate affords the described 2,3,4-triaminopyridine (VI), which is treated with HCl in THF in order to eliminate the acetonide group, providing the deprotected triaminopyridine derivative (XV). Finally, this compound is cyclized with formamidine (VII), triethyl orthoformate (XVI) or dimethylformamide dimethylacetal (XVII) in a suitable solvent.
【1】
Martín, L.; Leeson, P.A.; Castañer, J.; Sorbera, L.A.; AMP-579. Drugs Fut 2000, 25, 9, 900.
|
【2】
Reilly, L.W.; Vanasse, B.J.; Garcia, H.; Shah, H.C.; Leon, P.; O'Brien, M.K.; Walther, F.L.; Powner, T.H.; Tsuei, C.T.; Thompson, M.D. (Aventis Pharmaceuticals, Inc.); Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl]propyl]amino]-3H-imidazo[4,5-b]pyridin-3-yl]N-ethyl-2,3-dihydroxycyclopentanecarboxamide. WO 9825921 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
23849 |
N-(2-chloro-3-nitro-4-pyridinyl)-N-[(1R)-1-[(3-chloro-2-thienyl)methyl]propyl]amine; 2-chloro-N-[(1R)-1-[(3-chloro-2-thienyl)methyl]propyl]-3-nitro-4-pyridinamine
|
|
C13H13Cl2N3O2S |
详情 |
详情
|
(IV) |
23850 |
(3aR,4S,6R,6aS)-6-amino-N-ethyl-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxole-4-carboxamide
|
|
C11H20N2O3 |
详情 |
详情
|
(V) |
23851 |
(3aR,4S,6R,6aS)-6-[[4-([(1R)-1-[(3-chloro-2-thienyl)methyl]propyl]amino)-3-nitro-2-pyridinyl]amino]-N-ethyl-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxole-4-carboxamide
|
|
C24H32ClN5O5S |
详情 |
详情
|
(VI) |
23848 |
(2R)-1-(3-chloro-2-thienyl)-2-butanamine; (1R)-1-[(3-chloro-2-thienyl)methyl]propylamine
|
|
C8H12ClNS |
详情 |
详情
|
(VI) |
23852 |
(3aR,4S,6R,6aS)-6-[[3-amino-4-([(1R)-1-[(3-chloro-2-thienyl)methyl]propyl]amino)-2-pyridinyl]amino]-N-ethyl-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxole-4-carboxamide
|
|
C24H34ClN5O3S |
详情 |
详情
|
(VII) |
15369 |
Iminoformamide; Methanimidamide
|
463-52-5 |
CH4N2 |
详情 | 详情
|
(X) |
40489 |
2-hydroxy-4-methoxynicotinonitrile
|
|
C7H6N2O2 |
详情 |
详情
|
(XI) |
34269 |
2,4-pyridinediol
|
626-03-9 |
C5H5NO2 |
详情 | 详情
|
(XII) |
40490 |
3-nitro-2,4-pyridinediol
|
89282-12-2 |
C5H4N2O4 |
详情 | 详情
|
(XIII) |
40491 |
4-chloro-3-nitro-2(1H)-pyridinone
|
|
C5H3ClN2O3 |
详情 |
详情
|
(XIV) |
40492 |
4-([(1R)-1-[(3-chloro-2-thienyl)methyl]propyl]amino)-3-nitro-2-pyridinol
|
|
C13H14ClN3O3S |
详情 |
详情
|
(XV) |
40493 |
(1S,2R,3S,4R)-4-[[3-amino-4-([(1R)-1-[(3-chloro-2-thienyl)methyl]propyl]amino)-2-pyridinyl]amino]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide
|
|
C21H30ClN5O3S |
详情 |
详情
|
(XVI) |
21304 |
Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether
|
122-51-0 |
C7H16O3 |
详情 | 详情
|
(XVII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(VII) The condensation of 2-(2,6-dichlorophenyl)acetonitrile (I) with 3,6-dichloropyridazin-3-yl)acetonitrile (III), wich is condensed with 2,4-difluorothiophenol (IV) by means of NaH in THF to yield the thioether (V). The partial hydrolysis of the cyano group of (V) with conc. H2SO4 at 100 CC affords the acetamide (VI), wich is finally cyclized with N,N-dimethylformamidedimethylacetal (VII) in refluxing toluene te provide the target pyrimido-pyridazine derivative.
【1】
Salituro, F.G.; Duffy, J.P.; Murcko, M.A.; Bemis, G.W.; Su, M.; Wilson, K.P.; Cochran, J.E.; Harrington, E.M.; Galullo, V.P. (Vertex Pharmaceuticals Inc.); Substd. nitrogen containing heterocycles as inhibitors of p38 protein kinase. EP 0951467; JP 2001506266; WO 9827098 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18202 |
2-(2,6-dichlorophenyl)acetonitrile; 2,6-Dichlorophenylacetonitrile
|
3215-64-3 |
C8H5Cl2N |
详情 | 详情
|
(II) |
11292 |
3,6-Dichloropyridazine
|
141-30-0 |
C4H2Cl2N2 |
详情 | 详情
|
(III) |
60561 |
2-(2,6-dichlorophenyl)-2-(6-methyl-3-pyridazinyl)acetonitrile
|
|
C13H9Cl2N3 |
详情 |
详情
|
(IV) |
60562 |
2,4-difluorobenzenethiol; 2,4-difluorophenylhydrosulfide
|
|
C6H4F2S |
详情 |
详情
|
(V) |
60563 |
2-(2,6-dichlorophenyl)-2-{6-[(2,4-difluorophenyl)sulfanyl]-3-pyridazinyl}acetonitrile
|
|
C18H9Cl2F2N3S |
详情 |
详情
|
(VI) |
60564 |
2-(2,6-dichlorophenyl)-2-{6-[(2,4-difluorophenyl)sulfanyl]-3-pyridazinyl}acetamide
|
|
C18H11Cl2F2N3OS |
详情 |
详情
|
(VII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(IV) Malonic acid monoethyl ester (I) is converted into beta-ketoester (III) by formation of the corresponding trimethylsilyl ester with TMSCl and pyridine in ether followed by deprotonation with n-BuLi and acylation with cyclopropanecarbonyl chloride (II) in DME. Treatment of (III) with refluxing N,N-dimethylformamide dimethyl acetal (IV) affords enamine (V).
Quinoline-5-amine (VI) is first subjected to diazotation by treatment with NaNO2 in H2O/HCl, reduced with SnCl2.2H2O in HCl and isolated as the corresponding dihydrochloride salt (VII) by treatment with HCl.
Condensation of enamine (V) with hydrazine (VII) in the presence of Et3N in refluxing EtOH yields pyrazole ester (VIII), which is converted into acylguanidine (X) either by direct heating with guanidine (IX) in EtOH or by first transformation into the corresponding carboxylic acid (XI) by saponification with NaOH in refluxing MeOH, followed by treatment with refluxing thionyl chloride and reaction with guanidine hydrochloride (XII) under Schotten-Baumann conditions in refluxing THF/NaOH. Finally, treatment of the free base (X) with HCl in THF allows isolation of the corresponding monohydrochloride-monohydrate salt .
【1】
Wester, R.T.; Allen, M.C.; Guzman-Perez, A.; et al.; Discovery of zoniporide: A potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorg Med Chem Lett 2001, 11, 6, 803.
|
【2】
Guzman-Perez, A.; Ruggeri, R.B.; Wester, R.T.; Hamanaka, E.S.; Mularski, C.J. (Pfizer Inc.); N-[(Substd. five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivs. for the treatment of ischemia. EP 1056729; WO 9943663 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX),(XII) |
14790 |
Guanidine
|
113-00-8 |
CH5N3 |
详情 | 详情
|
(I) |
15086 |
3-ethoxy-3-oxopropionic acid
|
1071-46-1 |
C5H8O4 |
详情 | 详情
|
(II) |
14061 |
Cyclopropanecarbonyl chloride; Cyclopropanecarboxylic acid chloride
|
4023-34-1 |
C4H5ClO |
详情 | 详情
|
(III) |
15949 |
3-Cyclopropyl-3-oxo-propionic acid ethyl ester; ethyl 3-cyclopropyl-3-oxopropanoate
|
24922-02-9 |
C8H12O3 |
详情 | 详情
|
(IV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(V) |
48913 |
ethyl (Z)-3-amino-2-(cyclopropylcarbonyl)-2-propenoate
|
|
C9H13NO3 |
详情 |
详情
|
(VI) |
26799 |
5-Aminoquinoline; 5-quinolinamine
|
611-34-7 |
C9H8N2 |
详情 | 详情
|
(VII) |
48914 |
5-hydrazinoquinoline
|
|
C9H9N3 |
详情 |
详情
|
(VIII) |
48915 |
ethyl 5-cyclopropyl-1-(5-quinolinyl)-1H-pyrazole-4-carboxylate
|
|
C18H17N3O2 |
详情 |
详情
|
(X) |
48917 |
N''-[[5-cyclopropyl-1-(5-quinolinyl)-1H-pyrazol-4-yl]carbonyl]guanidine
|
|
C17H16N6O |
详情 |
详情
|
(XI) |
48916 |
5-cyclopropyl-1-(5-quinolinyl)-1H-pyrazole-4-carboxylic acid
|
|
C16H13N3O2 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(VI) Alkylation of 4-hydroxy-5-methoxy benzoic acid methyl ester (I) with 3-chloropropyl p-toluene sulfonate (III) by means of K2CO3 and methyl-tricapryl ammonium chloride (Aliquat 128) in refluxing acetone affords compound (III), which is then nitrated by means of HNO3 in HOAc to furnish 2-nitro derivative (IV). Reduction of the nitro moiety of (IV) by means of Fe in H2O/MeOH in the presence of ammonium chloride yields 2-amino compound (V), which is subjected to reaction with refluxing dimethylformamide dimethylacetal (VI) to provide amidine (VII). Condensation of (VII) with acetonitrile by means of n-BuLi in hexane/THF/HOAc gives substituted quinoline-carbonitrile (IX), whose hydroxyl group is replaced by a chlorine by treatment of (IX) with refluxing POCl3 to afford compound (X). Coupling of (X) with 2,4-dichloro-5-methoxyaniline (XI) in 2-ethoxyethanol in the presence of pyridine hydrochloride yields compound (XII), which is finally converted into the desired compound by condensation with 1-methylpiperazine (XII) by means of NaI in refluxing ethylene glycol dimethyl ether.
【1】
Boschelli, D.H.; Ye, F.; Wang, Y.D.; Dutia, M.; Johnson, S.L.; Wu, B.; Miller, K.; Powell, D.W.; Yaczko, D.; Young, M.; Tischler, M.; Arndt, K.; Discafani, C.; Etienne, C.; Gibbons, J.; Grod, J.; Lucas, J.; Weber, J.M.; Boschelli, F.; Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem 2001, 44, 23, 3965. |
【2】
Boschelli, D.H.; Dutia, M.; Ye, F.; et al.; Inhibition of SRC kinase activity by 4-phenylamino-3-quinolinecarbonitriles Part 2: Optimization of the side chain at C-7. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 145.
|
【3】
Boschelli, D.H.; Wang, Y.D.; Ye, F.; et al.; Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles. J Med Chem 2001, 44, 5, 822.
|
【4】
Tsou, H.-R.; Wissner, A.; Johnson, B.D.; Reich, M.F.; Floyd, M.B. Jr.; Kitchen, D.B. (American Cyanamid Co.); Substituted 3-cyano quinolines. US 6002008 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29176 |
methyl 4-hydroxy-3-methoxybenzoate
|
3943-74-6 |
C9H10O4 |
详情 | 详情
|
(II) |
19490 |
3-chloro-1-propanol
|
627-30-5 |
C3H7ClO |
详情 | 详情
|
(III) |
50008 |
methyl 4-(3-chloropropoxy)-3-methoxybenzoate
|
|
C12H15ClO4 |
详情 |
详情
|
(IV) |
50009 |
methyl 4-(3-chloropropoxy)-5-methoxy-2-nitrobenzoate
|
|
C12H14ClNO6 |
详情 |
详情
|
(V) |
50010 |
methyl 2-amino-4-(3-chloropropoxy)-5-methoxybenzoate
|
|
C12H16ClNO4 |
详情 |
详情
|
(VI) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VII) |
50011 |
methyl 4-(3-chloropropoxy)-2-[[(E)-(dimethylamino)methylidene]amino]-5-methoxybenzoate
|
|
C15H21ClN2O4 |
详情 |
详情
|
(VIII) |
37210 |
acetonitrile
|
75-05-8 |
C2H3N |
详情 | 详情
|
(IX) |
50012 |
7-(3-chloropropoxy)-4-hydroxy-6-methoxy-3-quinolinecarbonitrile
|
|
C14H13ClN2O3 |
详情 |
详情
|
(X) |
48519 |
4-chloro-7-(3-chloropropoxy)-6-methoxy-3-quinolinecarbonitrile
|
|
C14H12Cl2N2O2 |
详情 |
详情
|
(XI) |
50013 |
2,4-dichloro-5-methoxyphenylamine; 2,4-dichloro-5-methoxyaniline
|
|
C7H7Cl2NO |
详情 |
详情
|
(XII) |
50014 |
7-(3-chloropropoxy)-4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-3-quinolinecarbonitrile
|
|
C21H18Cl3N3O3 |
详情 |
详情
|
(XIII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线31
该中间体在本合成路线中的序号:
(VI) The alkylation of 4-hydroxy-3-methoxybenzoic acid methyl ester (I) with 3-(4-morpholinyl)propyl chloride (II) and tetrabutylammonium chloride in refluxing butanone gives 3-methoxy-4-[3-(4-morpholinyl)propoxy]benzoic acid methyl ester (III), which is nitrated with HNO3 in hot acetic acid to yield 5-methoxy-4-[3-(4-morpholinyl)propoxy]-2-nitrobenzoic acid methyl ester (IV). The reduction of (III) with H2 over Pd/C in methanol/ethyl acetate to afford the corresponding 2-amino ester (V), which is condensed with dimethylformamide dimethylacetal (VI) by heating at 100 C to provide the 2-(dimethylaminomethyleneamino) derivative (VII). The cyclization of (VII) with acetonitrile (VIII) by means of BuLi and CO2 in THF gives 6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-oxo-1,4-dihydroquinoline-3-carbonitrile (IX), which is treated with refluxing SOCl2 to yield the 4-chloroquinoline derivative (X). Finally, this compound is condensed with 2-bromo-5-methoxyaniline by means of pyridine hydrochloride in 2-ethoxyethanol or NaH in THF (or DMF).
【1】
Wang, Y.D.; et al.; Inhibition of SRC kinase activity by 4-phenylamino-3-quinolinecarbonitriles, Part 1: optimization of the aniline headpiece at C-4. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 144.
|
【2】
Tsou, H.-R.; Wissner, A.; Johnson, B.D.; Reich, M.F.; Floyd, M.B. Jr.; Kitchen, D.B. (American Cyanamid Co.); Substituted 3-cyano quinolines. US 6002008 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29176 |
methyl 4-hydroxy-3-methoxybenzoate
|
3943-74-6 |
C9H10O4 |
详情 | 详情
|
(II) |
18691 |
4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine |
7357-67-7 |
C7H14ClNO |
详情 | 详情
|
(III) |
50321 |
methyl 3-methoxy-4-[3-(4-morpholinyl)propoxy]benzoate
|
|
C16H23NO5 |
详情 |
详情
|
(IV) |
50322 |
methyl 5-methoxy-4-[3-(4-morpholinyl)propoxy]-2-nitrobenzoate
|
|
C16H22N2O7 |
详情 |
详情
|
(V) |
50323 |
methyl 2-amino-5-methoxy-4-[3-(4-morpholinyl)propoxy]benzoate
|
|
C16H24N2O5 |
详情 |
详情
|
(VI) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VII) |
50324 |
methyl 2-[[(E)-(dimethylamino)methylidene]amino]-5-methoxy-4-[3-(4-morpholinyl)propoxy]benzoate
|
|
C19H29N3O5 |
详情 |
详情
|
(VIII) |
50327 |
Cyanoethane; Ethyl cyanide; Propionitrile
|
107-12-0 |
C26H39NO5 |
详情 | 详情
|
(IX) |
50325 |
6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-oxo-1,4-dihydro-3-quinolinecarbonitrile
|
|
C18H21N3O4 |
详情 |
详情
|
(X) |
48517 |
4-chloro-6-methoxy-7-[3-(4-morpholinyl)propoxy]-3-quinolinecarbonitrile
|
|
C18H20ClN3O3 |
详情 |
详情
|
(XI) |
50326 |
2-Bromo-5-methoxyaniline
|
129968-11-2 |
C7H8BrNO |
详情 | 详情
|
合成路线32
该中间体在本合成路线中的序号:
(II) Heating of 5-acetylpyrimidine (I) with N,N-dimethylformamide dimethylacetal (II) affords 3-(dimethylamino)-1-(5-pyrimidinyl)-2-propen-1-one (III), which is cyclized with 1-(2-methyl-5-nitrophenyl)guanidine —prepared in situ by adding NaOH to the guanidine nitrate (IV) in 2-propanol at 120 °C— to provide 1-methyl-4-nitro-2-[4-(5-pyrimidinyl)pyrimidin-2-ylamino]benzene (V). The nitro group of compound (V) is then reduced to the corresponding aniline (VI) by catalytic transfer hydrogenation in the presence of formic acid and Pd/C in THF/MeOH. Benzylic bromination of 4-methyl-3-(trifluoromethyl)benzoic acid (VII) using sodium bromate and sodium bisulfite in isopropyl acetate gives 4-(bromomethyl)-3-(trifluoromethyl)benzoic acid (VIII), which is converted to the acid chloride (IX) by treatment with (COCl)2 and catalytic DMF in CH2Cl2. Acid chloride (IX) is then coupled with aniline (VI) in the presence of K2CO3 in dioxane to yield the 4-(bromomethyl)benzamide (X), from which the bromide group is finally displaced with (–)-(S)-3-(dimethylamino)pyrrolidine (XI) in the presence of K2CO3 in anhydrous DMF (1, 2). Scheme 1
【1】
Asaki, T., Sugiyama, Y., Hamamoto, T., Higashioka, M., Umehara, M., Naito, H., Niwa, T. Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors. Bioorg Med Chem Lett 2006, 16(5): 1421-5. |
【2】
Asaki, T., Sugiyama, Y., Segawa, J. (Nippon Shinyaku Co., Ltd.). Amide derivative and medicine. EP 1702917, US 2008293940, WO 2005063709. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65896 |
1-(5-Pyrimidinyl)ethanone; 5-Acetylpyrimidine |
10325-70-9 |
C6H6N2O |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
65897 |
3-(Dimethylamino)-1-(5-pyrimidinyl)-2-propen-1-one |
641615-34-1 |
C9H11N3O |
详情 | 详情
|
(IV) |
65898 |
(2-Methyl-5-nitrophenyl)guanidine nitrate; N-(2-Methyl-5-nitrophenyl)guanidine nitrate |
152460-08-7 |
C8H10N4O2.HNO3 |
详情 | 详情
|
(V) |
65899 |
2-Methyl-5-nitro-N-[4-(5-pyrimidinyl)pyrimidin-2-yl]aniline |
|
C15H12N6O2 |
详情 | 详情
|
(VI) |
65900 |
4-Methyl-N-3-(4-(pyrimidin-5-yl)pyrimidin-2-yl)benzene-1,3-diamine; 4-Methyl-3-[4-(5-pyrimidinyl)pyrimidin-2-ylamino]aniline |
641615-36-3 |
C15H14N6 |
详情 | 详情
|
(VII) |
65901 |
4-Methyl-3-(trifluoromethyl)benzoic acid |
261952-01-6 |
C9H7F3O2 |
详情 | 详情
|
(VIII) |
65902 |
4-Bromomethyl-3-(trifluoromethyl)benzoic acid |
|
C9H6BrF3O2 |
详情 | 详情
|
(IX) |
65903 |
4-Bromomethyl-3-trifluoromethylbenzoyl chloride |
948553-14-8 |
C9H5BrClF3O |
详情 | 详情
|
(X) |
65904 |
|
|
C24H18BrF3N6O |
详情 | 详情
|
(XI) |
65905 |
(3S)-N,N-dimethyl-3-pyrrolidinamine; N,N-dimethyl-N-[(3S)pyrrolidinyl]amine |
132883-44-4 |
C6H14N2 |
详情 | 详情
|
合成路线33
该中间体在本合成路线中的序号:
(II)
【1】
Kompella A, Bhujanga Rao AKS, Venkaiah Chowdary N, et aL 2004. Process for the preparation of the anti-cancer drug imatinib and its analogs via aminolysis of a (chloromethyl benzamide intermediate. WO 2004108699(本专利申请人为: Natco Pharma Limited, India) |
【2】
Szczepek W, Luniewski W, Kaczmarek L, et aL 2006.A process for preparation of imatinib base. W0 2006071130(本专利申请人为: Instytut Farmaceutyczny, Pol) |
【3】
Szakacs Z,Beni S,VargaZ,et aL 2005. Acid-base profiling of imatinib(gleevec) and its fragments. J Med Chem,8(1): 249一255 |
【4】
Zimmermann J.Buchdunger E, Mett H, et aL 1997. Potent and selective inhibitors of the abl-kinase: phenylaminopyrimidine (PAP) derivatives. Bioorg Med Chem Lett,7(2): 187~191 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12027 |
1-(3-Pyridinyl)-1-ethanone; 1-(3-Pyridinyl)ethanone
|
350-03-8 |
C7H7NO |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
47516 |
(E)-3-(dimethylamino)-1-(3-pyridinyl)-2-propen-1-one
|
123367-26-0 |
C10H12N2O |
详情 | 详情
|
合成路线34
该中间体在本合成路线中的序号:
(XXIX) Mitsunobu reaction of apocynin (XIII) with the cyclopropylmethanol derivatives (XIa-c) in the presence of DEAD, PPh3 and DIEA in THF affords the aryl ethers (XXVIIa-c), which by nitration with HNO3 in Ac2O yields the 6-nitrophenyl derivatives (XXVIIIa-c). Condensation of ketones (XXVIIIa-c) with dimethylformamide dimethylacetal (XXIX) in DMF at 100 °C furnishes keto-enamines (XXXa-c), which upon Leimgruber-Batcho reaction using Fe in AcOH at 80 °C produces quinoline derivatives (XXXIa-c). Chlorination of 4-hydroxyquinolines (XXXIa-c) with POCl3 at 85 °C gives their corresponding chlorides (XXXIIa-c). These compounds are alternatively obtained by Mitsunobu condensation of 4-chloro-7-hydroxy-6-methoxyquinoline (XXXIII) with alcohols (Xia-c) using DEAD and PPh3 in CH2Cl2 at 0 °C. Condensation of chlorides (XXXIIa-c) with 6-hydroxy-N-methyl-1-naphthamide (V) by means of DMAP in 2,6-lutidine at 140 °C yields ethers (XIIa-c), whose N-carbamates are cleaved by means of HBr in AcOH .
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIa) |
67635 |
benzyl (1-(hydroxymethyl)cyclopropyl)carbamate |
|
C12H15NO3 |
详情 |
详情
|
(XIb) |
67647 |
ethyl (1-(hydroxymethyl)cyclopropyl)carbamate |
|
C7H13NO3 |
详情 |
详情
|
(XIc) |
67648 |
tert-butyl (1-(hydroxymethyl)cyclopropyl)carbamate |
107017-73-2 |
C9H17NO3 |
详情 | 详情
|
(XXVIIa) |
67649 |
benzyl (1-((4-acetyl-2-methoxyphenoxy)methyl)cyclopropyl)carbamate |
|
C21H23NO5 |
详情 | 详情
|
(XXVIIb) |
67650 |
ethyl (1-((4-acetyl-2-methoxyphenoxy)methyl)cyclopropyl)carbamate |
|
C16H21NO5 |
详情 | 详情
|
(XXVIIc) |
67651 |
tert-butyl (1-((4-acetyl-2-methoxyphenoxy)methyl)cyclopropyl)carbamate |
|
C18H25NO5 |
详情 | 详情
|
(XXVIIIa) |
67653 |
benzyl (1-((4-acetyl-2-methoxy-5-nitrophenoxy)methyl)cyclopropyl)carbamate |
|
C21H22N2O7 |
详情 |
详情
|
(XXVIIIb) |
67654 |
ethyl (1-((4-acetyl-2-methoxy-5-nitrophenoxy)methyl)cyclopropyl)carbamate |
|
C16H20N2O7 |
详情 | 详情
|
(XXVIIIc) |
67652 |
tert-butyl (1-((4-acetyl-2-methoxy-5-nitrophenoxy)methyl)cyclopropyl)carbamate |
|
C18H24N2O7 |
详情 | 详情
|
(XXXa) |
67656 |
(E)-benzyl (1-((4-(3-(dimethylamino)acryloyl)-2-methoxy-5-nitrophenoxy)methyl)cyclopropyl)carbamate |
|
C24H27N3O7 |
详情 | 详情
|
(XXXb) |
67655 |
(E)-ethyl (1-((4-(3-(dimethylamino)acryloyl)-2-methoxy-5-nitrophenoxy)methyl)cyclopropyl)carbamate |
|
C19H25N3O7 |
详情 | 详情
|
(XXXc) |
67657 |
(E)-tert-butyl (1-((4-(3-(dimethylamino)acryloyl)-2-methoxy-5-nitrophenoxy)methyl)cyclopropyl)carbamate |
|
C21H29N3O7 |
详情 | 详情
|
(XXXIa) |
67658 |
benzyl (1-(((4-hydroxy-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropyl)carbamate |
|
C22H22N2O5 |
详情 | 详情
|
(XXXIb) |
67659 |
ethyl (1-(((4-hydroxy-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropyl)carbamate |
|
C17H20N2O5 |
详情 |
详情
|
(XXXIc) |
67660 |
tert-butyl (1-(((4-hydroxy-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropyl)carbamate |
|
C19H24N2O5 |
详情 | 详情
|
(XXXIIa) |
67663 |
benzyl (1-(((4-chloro-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropyl)carbamate |
|
C22H21ClN2O4 |
详情 | 详情
|
(XXXIIb) |
67662 |
ethyl (1-(((4-chloro-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropyl)carbamate |
|
C17H19ClN2O4 |
详情 | 详情
|
(XXXIIc) |
67661 |
tert-butyl (1-(((4-chloro-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropyl)carbamate |
|
C19H23ClN2O4 |
详情 | 详情
|
(V) |
67629 |
6-hydroxy-N-methyl-1-naphthamide |
|
C12H11NO2 |
详情 | 详情
|
(XIII) |
22604 |
1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone |
498-02-2 |
C9H10O3 |
详情 | 详情
|
(XXIX) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XXXIII) |
67664 |
4-chloro-6-methoxyquinolin-7-ol |
|
C10H8ClNO2 |
详情 | 详情
|
合成路线35
该中间体在本合成路线中的序号:
(II) In one method, condensation of decitabine (I) with N,N-dimethylformamide dimethylacetal (II) gives the formamidine derivative (III), which by enzymatic acetylation with vinyl acetate in the presence of immobilized lipozyme in acetonitrile/1,4-dioxane yields the primary acetate (IV). Condensation of the deoxyribofuranose derivative (IV) with 2-cyanoethyl N,N,N’,N’-tetraisopropylphosphorodiamidate (V) in CH2Cl2 provides the phosphorodiamidate (VI), which then condenses with the deoxyguanosine derivative (VII) in CH2Cl2 to afford the trisubstituted phosphite (VIII) . oxidation of phosphite (VIII) with t-BuOOH provides the corresponding phosphate (IX), which is fully deprotected by means of NH3 in MeOH, and finally salified using naoAc in H2O/EtoH .
【1】
Redkar, S. Scaleup and development of a process for a low-volume subcutaneous formulation of SGI-110, a potent hypomethylating agent. 103rd Annu Meet Am Assoc Cancer Res (AACR) (March 31-April 4, Chicago) 2012, Abst. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68188 |
decitabine;2-Desoxy-5-azacytidine;2'-Deoxy-5-azacytidine;5-Aza-2'-deoxycytidine;5-Azadeoxycytidine;Dacogen;1,3,5-Triazin-2(1H)-one,4-amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-;b-decitabine;s-Triazin-2(1H)-one,4-amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-(7CI,8CI) |
2353-33-5 |
C8H12N4O4 |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
68189 |
(Z)-N'-(5-((2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-oxo-4,5-dihydro-1,3,5-triazin-2-yl)-N,N-dimethylformimidamide |
|
C11H17N5O4 |
详情 | 详情
|
(IV) |
68190 |
((2S,3R,5S)-5-(4-((Z)-((dimethylamino)methylene)amino)-2-oxo-1,3,5-triazin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl acetate |
|
C13H19N5O5 |
详情 | 详情
|
(V) |
48656 |
2-Cyanoethyl N,N,N',N'-tetraisopropylphosphoramidite; 2-Cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite; Bis(diisopropylamino)-2-cyanoethoxyphosphine
|
102691-36-1 |
C15H32N3OP |
详情 | 详情
|
(VI) |
68191 |
((2S,3R,5S)-3-(((2-cyanoethoxy)(diisopropylamino)phosphino)oxy)-5-(4-((Z)-((dimethylamino)methylene)amino)-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate |
|
C22H36N7O6P |
详情 | 详情
|
(VII) |
68194 |
(2S,3R,5S)-5-(2-(2-(4-(tert-butyl)phenoxy)acetamido)-6-oxo-1H-purin-9(6H)-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl 2-(4-(tert-butyl)phenoxy)acetate |
|
C34H41N5O8 |
详情 | 详情
|
(VIII) |
68193 |
(2S,3R,5S)-2-((((((2S,3R,5S)-2-(acetoxymethyl)-5-(4-((Z)-((dimethylamino)methylene)amino)-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphino)oxy)methyl)-5-(2-(2-(4-(tert-butyl)phenoxy)acetamido)-6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3-yl 2-(4-(tert-butyl)phenoxy)acetate |
|
C50H62N11O14P |
详情 | 详情
|
(IX) |
68192 |
(2S,3R,5S)-2-((((((2S,3R,5S)-2-(acetoxymethyl)-5-(4-((Z)-((dimethylamino)methylene)amino)-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2-(2-(4-(tert-butyl)phenoxy)acetamido)-6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3-yl 2-(4-(tert-butyl)phenoxy)acetate |
|
C50H62N11O15P |
详情 | 详情
|
合成路线36
该中间体在本合成路线中的序号:
(XXIV) Uracil intermediate (I) is obtained as follows. Condensation of 2-fluoro-4-iodophenyl isocyanate (XIII) with cyclopropylamine (XIV) in Et2O , or alternatively reaction of 2-fluoro-4-iodoaniline (XV) with CDI in the presence of Et3N in DMF, followed by condensation with cyclopropylamine (XIV) affords disubstituted urea (XVI). Cyclization of urea (XVI) is treated with malonic acid (XVII) in the presence of AcCl in Ac2O at 60 °C affords the pyrimidine trione (XVIII), which is chlorinated using POCl3 in the presence of PhNMe2 and a catalytic amount of H2O at 90 °C to provide a mixture of 6-chloropyrimidine (XIX) and the corresponding regioisomer. Finally, chloropyrimidine (XIX) is treated with methylamine (XX) in EtOH at 80 °C .
In an alternative procedure, acylation of urea (XVI) with cyanoacetic acid (XXI) by means of MsCl in DMF yields the N-(cyanoacetyl)urea (XXII), which cyclizes in aqueous NaOH at 80 °C to yield the amino-pyrimidine derivative (XXIII). Condensation of amine (XXIII) with dimethylformamide dimethylacetal (XXIV) in DMF affords formamidine (XXV), which is finally reduced using NaBH4 in EtOH/t-BuOH .
【2】
Sakai, T., Kawasaki, H., Abe, H. et al. (Japan Tobacco, Inc.). 5-Amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer. CN 101912400, EP 1761528, EP 1894932, EP 2298768, JP 2008201788, JP 2008501631, US 2006014768, US 7378423, US 2008312228, US 201024013, WO 2005121142. |
【1】
Abe, H., Kikuchi, S., Hayakawa, K. et al. Discovery of a highly potent and selective MEK inhibitor: GSK1120212 (JTP-7407 DMSO solvate). ACS Med Chem Lett 2011, 2(4): 320. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68359 |
1-(2-fluoro-4-iodophenyl)-3-cyclopropyl-6-(methylamino)uracil;3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione |
|
C14H13FIN3O2 |
详情 |
详情
|
(XIII) |
68369 |
2-fluoro-4-iodophenyl isocyanate |
|
C7H3FINO |
详情 | 详情
|
(XIV) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(XV) |
63342 |
2-fluoro-4-iodoaniline; 2-fluoro-4-iodophenylamine
|
29632-74-4 |
C6H5FIN |
详情 | 详情
|
(XVI) |
68370 |
1-cyclopropyl-3-(2-fluoro-4-iodophenyl)urea |
|
C10H10FIN2O |
详情 | 详情
|
(XVII) |
12963 |
Malonic acid
|
141-82-2 |
C3H4O4 |
详情 | 详情
|
(XVIII) |
68371 |
1-cyclopropyl-3-(2-fluoro-4-iodophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione |
|
C13H10FIN2O3 |
详情 | 详情
|
(XIX) |
68372 |
6-chloro-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione |
|
C13H9ClFIN2O2 |
详情 | 详情
|
(XX) |
11021 |
Methanamine; Methylamine
|
74-89-5 |
CH5N |
详情 | 详情
|
(XXI) |
12591 |
Cyanoacetic Acid; 2-Cyanoacetic acid
|
372-09-8 |
C3H3NO2 |
详情 | 详情
|
(XXII) |
68373 |
2-cyano-N-cyclopropyl-N-((2-fluoro-4-iodophenyl)carbamoyl)acetamide |
|
C13H11FIN3O2 |
详情 | 详情
|
(XXIII) |
68374 |
6-amino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione |
|
C13H11FIN3O2 |
详情 | 详情
|
(XXIV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XXV) |
68375 |
(E)-N'-(1-cyclopropyl-3-(2-fluoro-4-iodophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-N,N-dimethylformimidamide |
|
C16H16FIN4O2 |
详情 | 详情
|
合成路线37
该中间体在本合成路线中的序号:
(XXXII) Condensation of ethyl 3-(dimethylamino)acrylate (XVIII) with (benzyloxy)acetyl chloride (XIX) by means of pyridine in CH2Cl2 gives ethyl 2-[(benzyloxy)acetyl]-3-(dimethylamino)-2-propenoate (XX), which by cyclocondensation with ethyl oxalyl chloride (XXI) in the presence of LiHMDS in THF at –78 °C followed by heating with NH4OAc and AcOH affords pyridone derivative (XXII). Alkylation of pyridone (XXII) with bromoacetaldehyde dimethyl acetal (XXIII) and Cs2CO3 in DMF yields diethyl 1-(2,2-dimethoxyethyl)-3-(benzyloxy)-1,4-dihydropyridine-2,5-dicarboxylate (XXIV), which can also be obtained by condensation of diethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (XXV) with 2,2-dimethoxyethylamine (XXVI) in EtOH. Hydrolysis of acetal (XXIV) with H2SO4 and HCOOH in CH2Cl2 yields aldehyde (XXVII), which upon cyclocondensation with 3(R)-amino-1-butanol (XI) by means of AcOH in refluxing MeOH/toluene provides the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (XXVIII). Hydrolysis of ester (XXVIII) with NaOH in THF/MeOH/H2O gives the corresponding free acid (XXIX), which is finally condensed with 2,4-difluorobenzylamine (XIV) in the presence of HATU and NMM in DMF .
Propenoate (XX) can also be prepared by condensation of ethyl 4-chloroacetoacetate (XXX) with PhCH2OH in the presence of t-AmONa to give benzyl ether (XXXI), which then reacts with N,N-dimethylformamide dimethyl acetal (XXXII) in toluene .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XVIII) |
16000 |
ethyl (E)-3-(dimethylamino)-2-propenoate; Ethyl trans-3-dimethylaminoacrylate
|
1117-37-9 |
C7H13NO2 |
详情 | 详情
|
(XIX) |
10493 |
2-(Benzyloxy)acetyl chloride; Benzyloxyacetyl chloride
|
19810-31-2 |
C9H9ClO2 |
详情 | 详情
|
(XX) |
68583 |
(E)-ethyl 4-(benzyloxy)-2-((dimethylamino)methylene)-3-oxobutanoate |
|
C16H21NO4 |
详情 | 详情
|
(XXI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XXII) |
68584 |
diethyl 3-(benzyloxy)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C18H19NO6 |
详情 | 详情
|
(XXIII) |
13183 |
2-Bromo-1,1-dimethoxyethane; 2-Bromo-1-methoxyethyl methyl ether; Bromoacetaldehyde dimethyl acetal
|
7252-83-7 |
C4H9BrO2 |
详情 | 详情
|
(XXIV) |
68585 |
1-(2,2-dimethoxyethyl)-3-(benzyloxy)-1,4-dihydropyridine-2,5-dicarboxylate diethyl;diethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C22H27NO8 |
详情 | 详情
|
(XXV) |
68586 |
diethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate |
|
C18H18O7 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXVII) |
68587 |
diethyl 3-(benzyloxy)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C20H21NO7 |
详情 | 详情
|
(XXVIII) |
68588 |
(4R,12aS)-ethyl 7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C22H24N2O6 |
详情 | 详情
|
(XXIX) |
68589 |
(4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C20H20N2O6 |
详情 | 详情
|
(XXX) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(XXXI) |
68590 |
ethyl 4-(benzyloxy)-3-oxobutanoate |
|
C13H16O4 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
合成路线38
该中间体在本合成路线中的序号:
(XXXII) Condensation of methyl 4-chloroacetoacetate (XXXIII) with PhCH2OH in the presence of t-AmONa in THF gives the benzyl ether (XXXIV), which is then condensed with N,N-dimethylformamide dimethyl acetal (XXXII) in dioxane to give methyl 2-[(benzyloxy) acetyl]-3-aminoacrylate (XXXV). Cyclocondensation of acrylate (XXXV) with dimethyl oxalate by means of t-BuONa provides the pyranone derivative (XXXVII), which is then reacted with aminoacetaldehyde dimethyl acetal (XXVI) at reflux to yield pyridone (XXXVIII). Hydrolysis of acetal (XXXVIII) with H2SO4 and HCOOH affords aldehyde (XXXIX), which upon cyclocondensation with 3(R)-amino-1-butanol (XI) in the presence of AcOH in refluxing MeOH/toluene gives the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (XL). Finally, methyl ester (XL) is condensed with 2,4-difluorobenzylamine (XIV) in the presence of AcOH in toluene .
Alternatively, coupling of methyl ester (XXXVIII) with 2,4-difluorobenzylamine (XIV) by means of AcOH in toluene/MeOH gives amide (XLI), which upon acetal hydrolysis with H2SO4 and HCOOH in toluene yields aldehyde (XLII). Finally, aldehyde (XLII) is submitted to cyclocondensation with 3(R)-amino-1-butanol (XI) in the presence of AcOH in refluxing MeOH/toluene .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XL) |
68597 |
(4R,12aS)-methyl 7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C21H22N2O6 |
详情 | 详情
|
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XXXIII) |
68591 |
methyl 4-chloro-3-oxobutanoate;Methyl 4-chloro-3-oxo-butanoate;Methyl 4-chloro-3-oxobutyrate;Methyl 4-chloroacetoacetate |
32807-28-6 |
C5H7ClO3 |
详情 | 详情
|
(XXXIV) |
68592 |
methyl 4-(benzyloxy)-3-oxobutanoate |
|
C12H14O4 |
详情 | 详情
|
(XXXV) |
68593 |
(E)-methyl 4-(benzyloxy)-2-((dimethylamino)methylene)-3-oxobutanoate;methyl 2-[(benzyloxy)acetyl]-3-aminoacrylate |
|
C15H19NO4 |
详情 | 详情
|
(XXXVI) |
37412 |
methyl 2-methoxy-2-oxoacetate;dimethyl oxalate;Methyl oxalate |
553-90-2 |
C4H6O4 |
详情 | 详情
|
(XXXVII) |
68594 |
dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate |
|
C16H14O7 |
详情 | 详情
|
(XXXVIII) |
68595 |
dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C20H23NO8 |
详情 | 详情
|
(XXXIX) |
68596 |
dimethyl 3-(benzyloxy)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C18H17NO7 |
详情 | 详情
|
(XLI) |
68598 |
methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate |
|
C26H26F2N2O7 |
详情 | 详情
|
(XLII) |
68599 |
methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylate |
|
C24H20F2N2O6 |
详情 | 详情
|
合成路线39
该中间体在本合成路线中的序号:
(XXXII) Condensation of methyl 4-methoxyacetoacetate (XLIII) with N,N-dimethylformamide dimethyl acetal (XXXII) produces methyl 3-(dimethylamino)-2-(methoxyacetyl)-2-propenoate (XLIV), which by reaction with 2,2-dimethoxyethylamine (XXVI) in MeOH affords the N-(dimethyoxyethyl)enamine (XLV). Cyclization of enaminoketone (XLV) with dimethyl oxalate (XXXVI) by means of LiH at 40 °C gives the dimethyl pyridone-dicarboxylate (XLVI), which by selective hydrolysis with LiOH yields the monocarboxylic acid (XLVII). Hydrolysis of acetal (XLVII) with MsOH and AcOH in acetonitrile at 58-65 °C followed by in situ cyclization of the resulting aldehyde (XLVIII) with 3(R)-amino-1-butanol (XI) in acetonitrile at 64 °C affords the pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (XLIX). Activation of acid (XLIX) with CDI in DME at 80 °C and subsequent coupling with 2,4-difluorobenzylamine (XIV) gives amide (L), which is finally O-demethylated with either MgBr2 in hot acetonitrile or LiBr in refluxing THF .
【1】
Wang, H., Goodman, S.N., Mans, D., Kowalski, M. (GlaxoSmithKline, Inc.). Process for preparing carbamoylpyridone derivatives and intermediates. WO 2011119566. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XXXVI) |
37412 |
methyl 2-methoxy-2-oxoacetate;dimethyl oxalate;Methyl oxalate |
553-90-2 |
C4H6O4 |
详情 | 详情
|
(XLIII) |
26655 |
methyl 4-methoxy-3-oxobutanoate;Methyl 4-methoxyacetoacetate;Methyl 4-methoxy-3-oxo-butanoate |
41051-15-4 |
C6H10O4 |
详情 | 详情
|
(XLIV) |
68600 |
methyl 3-(dimethylamino)-2-(methoxyacetyl)-2-propenoate;(Z)-methyl 2-((dimethylamino)methylene)-4-methoxy-3-oxobutanoate |
|
C9H15NO4 |
详情 | 详情
|
(XLV) |
68601 |
(Z)-methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate |
|
C11H19NO6 |
详情 | 详情
|
(XLVI) |
68602 |
dimethyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C14H19NO8 |
详情 | 详情
|
(XLVII) |
68603 |
1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid |
|
C13H17NO8 |
详情 | 详情
|
(XLVIII) |
68604 |
5-methoxy-6-(methoxycarbonyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-3-carboxylic acid |
|
C11H11NO7 |
详情 | 详情
|
(XLIX) |
68606 |
(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C14H16N2O6 |
详情 | 详情
|
(L) |
68605 |
(4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C21H21F2N3O5 |
详情 | 详情
|
合成路线40
该中间体在本合成路线中的序号:
(XXXII) Condensation of ethyl 4-chloro-3-oxobutyrate (XXX) with N,Ndimethylformamide dimethylacetal (XXXII) in EtOAc results in ethyl 2-(chloroacetyl)-3-(dimethylamino)-2-propenoate (LI), which by cyclocondensation with ethyl oxalyl chloride (XXI) by means of LiHMDS in THF affords diethyl 3-chloro-4-oxopyran-2,5-dicarboxylate (LII). Condensation of pyranone (LII) with 2,2-dimethoxyethylamine (XXVI) in EtOH gives pyridone (LIII), which is then hydrolyzed using HCOOH and H2SO4 in CH2Cl2 to yield the corresponding aldehyde (LIV). Cyclization of compound (LIV) with 3(R)-amino-1-butanol (XI) and AcOH in refluxing MeOH/toluene provides the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (LV), which by hydrolysis with KOSiMe3 in DME affords the hydroxy acid (LVI). Finally, acid (LVI) is coupled with 2,4-difluorobenzylamine (XIV) in the presence of HATU and NMM in DMF .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XXI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXX) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(LI) |
68607 |
ethyl 2-(chloroacetyl)-3-(dimethylamino)-2-
propenoate;(E)-ethyl 4-chloro-2-((dimethylamino)methylene)-3-oxobutanoate |
|
C9H14ClNO3 |
详情 | 详情
|
(LII) |
68608 |
diethyl 3-chloro-4-oxo-4H-pyran-2,5-dicarboxylate |
|
C11H11ClO6 |
详情 | 详情
|
(LIII) |
68609 |
diethyl 3-chloro-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C15H20ClNO7 |
详情 | 详情
|
(LIV) |
68610 |
diethyl 3-chloro-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C13H14ClNO6 |
详情 | 详情
|
(LV) |
68612 |
(4R,12aS)-ethyl 7-chloro-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C15H17ClN2O5 |
详情 | 详情
|
(LVI) |
68611 |
(4R,12aS)-7-chloro-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C13H13ClN2O5 |
详情 | 详情
|
合成路线41
该中间体在本合成路线中的序号:
(XXXII) Condensation of ethyl 3-oxobutyrate (LVII) with N,N-dimethylformamide dimethylacetal (XXXII) in EtOAc affords ethyl 2-acetyl-3-(dimethylamino)-2-propenoate (LVIII), which by cyclocondensation with ethyl oxalyl chloride (XXI) by means of LiHMDS in THF provides diethyl 4-oxopyran-2,5-dicarboxylate (LIX). Condensation of pyranone derivative (LIX) with 2,2-dimethoxyethylamine (XXVI) in EtOH gives pyridone (LX), which is then brominated with NBS in DMF to yield the 3-bromopyridin-4-one derivative (LXI). Hydrolysis of acetal (LXI) using HCOOH and H2SO4 in CH2Cl2 yields the corresponding aldehyde (LXII), which is cyclized with 3(R)-aminobutan-1-ol (XI) in the presence of AcOH in refluxing MeOH/toluene to afford the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (LXIII). Finally, bromo ester (LXIII) is submitted to treatment with KOSiMe3 in DME .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XXI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(LVI) |
68611 |
(4R,12aS)-7-chloro-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C13H13ClN2O5 |
详情 | 详情
|
(LVII) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(LVIII) |
68613 |
ethyl 2-acetyl-3-(dimethylamino)-2-propenoate;Ethyl 2-acetyl-3-(dimethylamino)acrylate;Ethyl (2E)-2-(dimethylaminomethylidene)-3-oxobutanoate |
51145-57-4 |
C9H15NO3 |
详情 | 详情
|
(LIX) |
68614 |
diethyl 4-oxopyran-2,5-dicarboxylate;diethyl 4-oxo-4H-pyran-2,5-dicarboxylate |
|
C11H12O6 |
详情 | 详情
|
(LX) |
68615 |
diethyl 1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C15H21NO7 |
详情 | 详情
|
(LXI) |
68616 |
diethyl 3-bromo-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C15H20BrNO7 |
详情 | 详情
|
(LXII) |
68617 |
diethyl 3-bromo-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C13H14BrNO6 |
详情 | 详情
|
(LXIII) |
68618 |
(4R,12aS)-ethyl 7-bromo-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C15H17BrN2O5 |
详情 | 详情
|
合成路线42
该中间体在本合成路线中的序号:
(IX) Condensation of the ortho-metalated derivative of 3-fluoroanisole (I) –generated in situ by treatment of anisole (I) with BuLi in THF at –78 °C– with 6-chloro-2-phenyl-3,1-benzoxazin-4-one (II) gives the diaryl ketone (III), which is N-deprotected by means of KOH in refluxing MeOH/H2O, yielding the aniline derivative (IV). Diazotization of amine (IV) with NaNO2 and HCl in AcOH/H2O, followed by treatment with I2 in the presence of KI in cold EtOAc/H2O affords the aryl iodide (V). Iodobenzophenone (V) is then subjected to Heck coupling with N-Boc-propargylamine (VI) in the presence of PdCl2(PPh3)2, CuI and Et2NH in CH2Cl2 to provide adduct (VII), which is submitted sequentially to triple bond hydration, N-Boc deprotection and cyclization by sequential treatment with HgSO4 and formic acid in CH2Cl2 at 0 °C, and then DIEA in CH2Cl2 or by treatment with HCl in dioxane/H2O and then Na2CO3 in CH2Cl2 to give the 3,4-dihydro[2]benzoazepinone (VIII). Condensation of benzazepinone (VIII) with N,Ndimethylformamide dimethylacetal (IX) in toluene at 80 °C yields the 4-(dimethylaminomethylene)[2]benzoazepinone derivative (X) , which is finally condensed with methyl 4-guanidino-2-methoxybenzoate hydrochloride (XI) in the presence of K2CO3 in refluxing MeOH .
Intermediate (XI) is prepared by condensation of methyl 4-amino-2-methoxybenzoate (XII) with chloroformamidine hydrochloride (XIII) in Me2SO2 at 120 °C, followed by acidification with TFA to yield methyl 4-guanidino-2-methoxybenzoate trifluoroacetate salt (XIV). Subsequent treatment of the trifluoroacetate salt with HCl at 80 °C provides the corresponding hydrochloride (XIV) .
【1】
Claiborne, C.F., Payne, L.J., Boyce, R.J. et al. (Millennium Pharmaceuticals, Inc.). Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase. EP 1771450, EP 1905773, JP 200753768, JP 2008285484, US 200525602, US 7572784, WO 2005111039. |
【2】
Claiborne, C.F., Sells, T.B., Stroud, S.G. (Millennium Pharmaceuticals, Inc.). Compounds for inhibiting mitotic progression. EP 2086981, JP 2010510215, US 2008167292, WO 2008963525. |
【3】
Sugiki, M., Sagi, K., Fujita, K., Kayahara, T., Takehana, S., Sakurai, K., Tashiro, K., (Ajinomoto Co., Inc.). Amidinophenylpyruvic acid derivative. US 2003109547, US 6710056, WO 2001042199. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
69123 |
1-fluoro-3-methoxybenzene;3-Fluoroanisole;m-Fluoroanisole |
456-49-5 |
C7H7FO |
详情 | 详情
|
(II) |
69124 |
6-chloro-2-phenyl-3,1-benzoxazin-4-one;6-chloro-2-phenyl-4H-benzo[d][1,3]oxazin-4-one |
|
C14H8ClNO2 |
详情 | 详情
|
(III) |
69125 |
(2-(benzylamino)-5-chlorophenyl)(2-fluoro-6-methoxyphenyl)methanone |
|
C21H17ClFNO2 |
详情 | 详情
|
(IV) |
69126 |
(2-amino-5-chlorophenyl)(2-fluoro-6-methoxyphenyl)methanone |
|
C14H11ClFNO2 |
详情 | 详情
|
(V) |
69127 |
(5-chloro-2-iodophenyl)(2-fluoro-6-methoxyphenyl)methanone |
|
C14H9ClFIO2 |
详情 | 详情
|
(VI) |
69128 |
tert-butyl prop-2-yn-1-ylcarbamate;tert-butyl prop-2-yn-1-ylcarbamate;N-Boc-propargylamine;N-(tert-Butoxycarbonyl)propargyl amine |
92136-39-5 |
C8H13NO2 |
详情 | 详情
|
(VII) |
69129 |
tert-butyl (3-(4-chloro-2-(2-fluoro-6-methoxybenzoyl)phenyl)prop-2-yn-1-yl)carbamate |
|
C22H21ClFNO4 |
详情 | 详情
|
(VIII) |
69130 |
8-chloro-1-(2-fluoro-6-methoxyphenyl)-3H-benzo[c]azepin-5(4H)-one |
|
C17H13ClFNO2 |
详情 | 详情
|
(IX) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(X) |
69131 |
(Z)-8-chloro-4-((dimethylamino)methylene)-1-(2-fluoro-6-methoxyphenyl)-3H-benzo[c]azepin-5(4H)-one |
|
C20H18ClFN2O2 |
详情 | 详情
|
(XI) |
69132 |
4-guanidino-2-methoxybenzoic acid hydrochloride |
342908-52-5 |
C9H11N3O3.HCl |
详情 | 详情
|
(XII) |
12416 |
methyl 4-amino-2-methoxybenzoate
|
27492-84-8 |
C9H11NO3 |
详情 | 详情
|
(XIII) |
69133 |
chloroformamidine hydrochloride;carbamimidic chloride hydrochloride |
|
CH3ClN2.HCl |
详情 | 详情
|
(XIV) |
69134 |
methyl 4-guanidino-2-methoxybenzoate trifluoroacetate salt;methyl 4-guanidino-2-methoxybenzoate 2,2,2-trifluoroacetate |
|
C10H13N3O3.C2HF3O2 |
详情 | 详情
|